This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
L02BG Aromatase inhibitors
RX_L02BG
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
12109 |
4. Check minimum number of events
Min. number of events
3
|
12109 |
5. Include endpointsNone |
12109 |
6. Filter based on genotype QC (FinnGen only) |
12109 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
L02BG Aromatase inhibitors
based on the number of shared cases.
Similar with more cases:
- Medicines for HER+ breast cancer
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 12109 | 11980 | 129 |
| Unadjusted period prevalence (%) | 4.04 | 4.08 | 0.06 |
| Median age at first event (years) | 63.88 | 64.09 | 43.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 9881
- Matched controls
- 98807
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
16.3
323.0
1023
697
1CD02
NOMESCO Finland
NA
41.7
323.0
541
137
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
14.8
323.0
1520
1198
A03FA01
ATC
metoclopramide; systemic, rectal
7.6
323.0
5592
14417
115
Kela drug reimbursment
Breast cancer
459.5
323.0
9252
3066
ZX080
NOMESCO Finland
Image guided radiotherapy
16.2
323.0
925
624
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
20.6
323.0
990
532
L02BG03
ATC
anastrozole; oral
242.7
323.0
2043
106
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
15.2
323.0
942
681
HAC20
NOMESCO Finland
Total mastectomy
30.3
323.0
3522
1774
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
9.3
323.0
7977
30761
C50
ICD-10 Finland
Malignant neoplasm of breast
19.5
323.0
1583
956
1501
Kela drug reimbursment
Palbociclib
181.0
323.0
515
30
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
42.8
323.0
604
150
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
19.2
323.0
1493
906
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
27.7
323.0
1327
551
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
25.0
323.0
1121
503
A04AA02
ATC
granisetron; systemic, transdermal
13.3
323.0
2587
2557
L01XE33
ATC
[U] palbociclib; oral
264.3
323.0
381
15
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
37.1
323.0
501
142
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
16.9
323.0
3338
2903
394
Kela drug reimbursment
Palbociclib
177.4
323.0
457
27
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
22.6
323.0
576
270
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
75.7
323.0
477
66
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
13.4
323.0
760
609
L02BG06
ATC
exemestane; oral
318.3
323.0
1734
66
L03AA14
ATC
lipegfilgrastim; parenteral
13.8
323.0
845
663
ZX120
NOMESCO Finland
Intravenous
4.0
323.0
1676
4851
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
16.2
323.0
1036
709
XX3DW
NOMESCO Finland
Time consuming IT work
6.8
323.0
2642
5048
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.0
323.0
5313
22439
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
29.1
323.0
1014
386
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
21.8
323.0
2234
1309
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.3
323.0
4063
13928
HAB99
NOMESCO Finland
Other partial excision of mammary gland
10.9
323.0
1251
1302
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
79.0
323.0
2665
460
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
18.7
323.0
924
543
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
30.7
323.0
4822
2976
L02BA01
ATC
tamoxifen; oral
28.1
323.0
3045
1542
C50.99
ICD-10 Finland
Breast, unspecified
17.1
323.0
1841
1303
N63
ICD-10 Finland
Unspecified lump in breast
4.1
323.0
1430
3896
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
18.0
323.0
1374
877
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
26.3
323.0
1612
726
HA1AA
NOMESCO Finland
X-ray mammography
21.4
323.0
5089
4678
192
Kela drug reimbursment
Fulvestrant
209.2
323.0
478
24
L02BG04
ATC
letrozole; oral
553.9
323.0
8328
942
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
15.2
323.0
1933
1551
H02AB02
ATC
dexamethasone; systemic
16.0
323.0
4605
5101
A04AD12
ATC
aprepitant; systemic
19.2
323.0
1102
642
L03AA13
ATC
pegfilgrastim; parenteral
17.3
323.0
2061
1486
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
32.5
323.0
3234
1457
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
20.5
323.0
1047
569
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
19.6
323.0
1293
751
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
20.7
323.0
960
511
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
15.9
323.0
1241
882
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
17.6
323.0
677
412
WF003
NOMESCO Finland
Adjuvant radiotherapy
11.4
323.0
1357
1360
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
5.5
323.0
1035
2053
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
24.5
323.0
1129
517
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
17.3
323.0
1973
1404
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
19.7
323.0
2895
2030
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
24.1
323.0
1590
779
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
18.1
323.0
1476
949
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
17.8
323.0
2703
2051
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.0
323.0
3680
2987
A04AA55
ATC
palonosetron, combinations; systemic
17.8
323.0
1663
1112
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
15.7
323.0
649
439
NK6AN
NOMESCO Finland
Total body bone isotope imaging
29.6
323.0
1197
458
ZX090
NOMESCO Finland
Other technic of radiotherapy
12.9
323.0
1018
871
JN4BD
NOMESCO Finland
Extensive body CT
4.8
323.0
2198
5578
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
13.7
323.0
689
538
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.5
323.0
2874
3699
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
22.3
323.0
3112
1992
L02BA03
ATC
fulvestrant; parenteral
193.9
323.0
515
28
X76
ICPC
Malignant neoplasm breast female
29.4
323.0
1521
608
PJA12
NOMESCO Finland
Sentinel node biopsy
34.8
323.0
5955
4130
TQW20
NOMESCO Finland
Tatoe
16.3
323.0
604
394
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
16.1
323.0
581
381
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
21.0
323.0
4388
3614
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
17.0
319.2
522
323
WZC30
NOMESCO Finland
Teaching
3.1
313.0
1999
7407
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.8
311.1
760
1048
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
9.7
301.4
642
704
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
10.9
298.2
596
580
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
17.8
290.6
467
275
PJW99
NOMESCO Finland
Other operation on lymphatic system
44.7
287.4
358
83
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.1
286.5
838
1482
R4110
NOMESCO Finland
Physiotherapy
2.3
286.4
3466
18515
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
25.0
281.7
404
168
Z31.5
ICD-10 Finland
Genetic counselling
5.1
281.4
953
2006
A04AA01
ATC
ondansetron; systemic, rectal
3.8
277.4
1298
3749
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
18.6
277.2
438
246
M05BX04
ATC
denosumab; parenteral
4.1
276.0
1197
3231
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
9.7
272.3
577
625
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
12.8
266.9
492
404
L01EF01
ATC
palbociclib; oral
187.1
261.8
273
15
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
25.0
257.4
369
153
ZX112
NOMESCO Finland
Subcutaneous
9.2
255.2
558
638
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
11.3
254.4
498
463
XX1XN
NOMESCO Finland
Other isotope examination
15.7
246.6
415
275
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
22.7
244.0
360
164
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
240.6
4358
27304
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.6
230.2
492
539
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.6
227.4
620
992
TQB05
NOMESCO Finland
Puncture of skin of trunk
16.7
222.0
364
225
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
16.3
217.5
360
228
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
12.0
212.3
402
348
L03AA02
ATC
filgrastim; parenteral
6.2
209.6
601
1026
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
28.0
206.2
286
105
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
33.1
204.0
271
84
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
25.9
202.5
287
114
Z51.0
ICD-10 Finland
Radiotherapy session
12.5
202.0
375
311
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
15.6
201.4
339
224
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
27.6
200.3
279
104
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
23.5
198.8
290
127
FM1FN
NOMESCO Finland
Heart function isotope examination
20.9
195.0
295
145
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
21.8
194.2
290
137
ZZR10
NOMESCO Finland
Flap of skin and muscle
12.8
187.0
343
277
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.7
184.9
893
2604
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
15.0
183.5
314
216
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
14.8
180.2
310
216
WX702
NOMESCO Finland
Supraglottic ventilation device
3.7
179.0
858
2484
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
16.1
176.9
294
188
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
14.3
176.0
307
221
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
29.6
175.8
240
83
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
17.6
172.4
277
162
L01BC06
ATC
capecitabine; oral
4.6
171.7
641
1474
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
9.0
169.8
375
433
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
13.6
169.1
301
227
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
4.8
168.7
601
1316
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
8.3
168.4
389
484
WX402
NOMESCO Finland
General anaesthesia
2.2
168.3
1939
9670
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.4
167.3
340
338
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
15.4
165.1
279
186
A79
ICPC
Malignancy NOS
9.9
163.4
341
356
1XC03
NOMESCO Finland
NA
31.1
162.5
219
72
ZZF00
NOMESCO Finland
Graft of adipose tissue
11.6
162.1
311
276
L02AE02
ATC
leuprorelin; implant, parenteral
13.1
160.3
290
227
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
19.8
157.3
242
125
L01CA04
ATC
vinorelbine; systemic
15.1
154.7
263
178
HAE99
NOMESCO Finland
Other reconstruction of breast
10.2
154.2
316
319
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
14.3
153.9
268
192
JN4AD
NOMESCO Finland
Body CT examination
3.0
153.8
1004
3636
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
19.0
153.1
239
129
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
152.3
2910
17752
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
17.6
151.6
243
141
N02BE01
ATC
paracetamol; systemic, rectal
2.3
150.9
8959
79725
B01AB05
ATC
enoxaparin; parenteral
1.8
150.3
3583
23567
HA1BA
NOMESCO Finland
Extensive X-ray mammography
11.7
144.7
276
242
ZXA05
NOMESCO Finland
Left side
1.9
143.8
3027
19019
ZXA00
NOMESCO Finland
Right side
1.8
142.2
3198
20531
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
14.0
139.1
244
178
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
14.5
138.8
240
169
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
138.5
1178
4988
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
8.8
137.4
306
358
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.5
136.4
694
2094
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
24.3
134.0
193
81
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.8
132.4
318
420
HA1HA
NOMESCO Finland
Tomosynthesis mammography
12.9
130.2
237
188
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
20.2
129.7
198
100
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
14.9
129.5
221
151
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
127.8
4415
32034
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.9
126.6
556
1482
HA1SA
NOMESCO Finland
Expansion mammography
15.4
124.2
209
138
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
11.0
122.0
240
224
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
20.0
121.0
185
94
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.4
119.8
621
1896
X19
ICPC
Breast lump/mass female
5.6
119.2
365
671
X21
ICPC
Breast sympt/compl female other
4.7
117.4
424
937
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
37.1
116.3
150
41
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
13.6
114.9
204
153
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
9.1
114.9
250
281
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
18.1
114.2
181
102
L02AE03
ATC
goserelin; implant
10.4
114.1
230
225
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
110.3
4092
29853
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
33.7
108.5
143
43
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
23.3
107.2
156
68
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
9.3
107.0
230
253
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
20.2
107.0
163
82
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
28.5
106.2
146
52
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
16.5
105.0
172
106
N06AX16
ATC
venlafaxine; oral
2.0
100.3
1532
8402
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.5
99.2
370
844
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
8.8
99.1
220
256
HAD99
NOMESCO Finland
Other plastic operation on breast
9.6
98.7
208
221
M05BA02
ATC
clodronic acid; systemic
18.6
98.4
154
84
A02BC02
ATC
pantoprazole; systemic
1.6
98.0
6746
56756
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
4.1
98.0
407
1029
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
28.4
96.1
132
47
R50.9
ICD-10 Finland
Fever, unspecified
2.1
95.5
1291
6736
JN4CD
NOMESCO Finland
Very extensive body CT
3.3
94.9
504
1563
8520/3-C50.8
ICD-O-3
Lobular carcinoma, NOS, of overlapping lesion of breast
61.8
93.9
110
18
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
8.5
93.2
211
254
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
17.8
92.0
146
83
Z3231
NOMESCO Finland
Registered nurse
1.7
91.8
2672
18014
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
14.5
88.5
152
106
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
18.1
88.0
139
78
J01DB01
ATC
cefalexin; oral
1.6
87.2
7890
69816
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.6
85.8
260
472
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.7
85.2
305
667
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.7
85.2
391
1079
XX1AD
NOMESCO Finland
Other CT-examination
10.7
83.9
166
157
HAD40
NOMESCO Finland
Mastopexy
9.7
83.4
174
182
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
11.3
83.0
160
144
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
9.7
82.4
172
180
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
6.0
81.7
236
404
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
40.1
81.4
103
26
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
11.1
80.7
157
144
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
7.0
80.3
205
297
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
47.1
80.0
98
21
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
3.1
79.6
480
1626
Z51.5
ICD-10 Finland
Palliative care
2.6
79.4
625
2501
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
16.1
77.1
127
80
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.7
76.4
271
587
HAC25
NOMESCO Finland
Radical mastectomy
8.8
76.4
168
193
Z3226
NOMESCO Finland
Physiotherapist
1.7
75.7
1922
12354
8522/3-C50.4
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast
44.7
75.2
93
21
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
9.7
75.1
157
165
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
33.4
73.0
96
29
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
21.4
72.6
108
51
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
8.0
71.7
167
211
HAF00
NOMESCO Finland
Excision of local recurrence of breast cancer
51.0
71.3
86
17
X26
ICPC
Fear of breast cancer female
6.6
70.6
187
286
J01MA12
ATC
levofloxacin; systemic
1.7
68.8
1678
10625
3AA13
NOMESCO Finland
NA
18.3
68.3
107
59
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
68.0
665
2980
ZSZ10
NOMESCO Finland
Secondary repair operation
35.5
67.9
88
25
WF004
NOMESCO Finland
Palliative radiotherapy
4.7
67.8
241
524
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
67.3
1087
6019
A46
ICD-10 Finland
Erysipelas
1.8
66.8
1223
7073
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.2
65.2
711
3351
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
15.5
63.6
106
69
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
18.5
63.5
99
54
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
62.8
912
4847
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
9.0
62.5
135
151
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
21.1
61.7
92
44
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.3
61.6
240
572
N02AA05
ATC
oxycodone; systemic
1.7
61.0
1373
8458
N62
ICD-10 Finland
Hypertrophy of breast
2.4
59.3
537
2313
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.3
58.5
226
534
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
10.5
58.3
116
112
B01AB10
ATC
tinzaparin; parenteral
2.0
57.6
777
4005
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
12.0
57.1
106
89
ZXE00
NOMESCO Finland
One hour or less
1.4
56.9
3686
29059
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
148.4
55.9
59
*
QBJ00
NOMESCO Finland
Liposuction in trunk
7.5
55.8
135
182
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.6
55.3
258
722
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.3
54.7
292
908
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.2
53.0
210
509
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
5.9
52.9
152
260
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
11.8
52.3
98
84
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.0
52.2
321
1102
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
7.8
50.6
119
154
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
49.8
1244
7862
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.9
49.7
169
352
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
7.4
49.5
121
166
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
24.8
48.8
69
28
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
12.9
48.1
86
67
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
47.8
510
2376
N97.0
ICD-10 Finland
Female infertility associated with anovulation
5.4
47.4
147
276
WX110
NOMESCO Finland
Local anesthesy
1.4
47.3
6239
54900
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
10.5
46.6
92
88
8520/3-C50.3
ICD-O-3
Lobular carcinoma, NOS, of lower-inner quadrant of breast
55.3
46.5
55
10
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
46.0
8574
80135
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
50.2
45.7
55
11
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
17.3
45.3
72
42
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.8
44.9
296
1062
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.5
44.4
390
7426
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
3.2
44.3
248
800
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
44.1
560
2811
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
9.5
41.8
87
92
SPAT1269
SPAT
Other puncture and/or drainage
6.0
41.8
118
198
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
4.3
41.4
158
371
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.2
40.8
221
697
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
40.7
687
3836
TQW99
NOMESCO Finland
Other minor procedure on skin
2.1
40.1
501
2496
G03GA05
ATC
follitropin alfa; parenteral
3.6
39.7
183
509
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
9.8
39.7
81
83
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.6
39.6
298
1161
H01CC01
ATC
ganirelix; parenteral
4.3
39.1
148
345
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
10.9
38.9
75
69
QBA00
NOMESCO Finland
Puncture of skin of trunk
7.1
38.9
97
138
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
6.1
38.6
107
176
S18
ICPC
Laceration/cut
1.3
38.4
3863
32121
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
38.3
1104
7213
WF002
NOMESCO Finland
Radical radiotherapy
2.6
38.2
294
1161
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
20.1
37.3
56
28
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
6.6
36.9
97
149
5BX04
NOMESCO Finland
NA
49.1
36.6
44
9
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
4.2
36.5
144
350
B29
ICPC
Lymph/immune mech sympt/complt other
6.7
35.9
93
140
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
35.8
424
2067
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
4.4
35.0
129
294
L02BA02
ATC
toremifene; oral
12.7
34.7
62
49
N05CF01
ATC
zopiclone; oral
1.3
34.3
3127
25499
HA1DA
NOMESCO Finland
Restricted mammography
10.5
34.2
67
64
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.9
34.0
142
364
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.7
33.8
118
255
3030
Kela drug reimbursment
Abemaciclib
92.9
33.7
37
*
1515
Kela drug reimbursment
NA
92.9
33.7
37
*
N61
ICD-10 Finland
Inflammatory disorders of breast
2.8
33.2
224
819
SPAT1152
SPAT
Removal of foreign body from under the skin
2.4
32.6
292
1250
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
72.4
31.8
36
5
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
10.2
31.7
63
62
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
31.5
1708
12751
WX704
NOMESCO Finland
Intubation
1.8
31.3
612
3576
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
4.2
30.7
119
286
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
30.6
267
1128
TLW00
NOMESCO Finland
Insemination
4.8
30.5
103
215
JN5AN
NOMESCO Finland
Total body isotope imaging
27.4
30.1
41
15
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.5
30.1
144
415
1XC13
NOMESCO Finland
NA
28.7
29.7
40
14
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
155.5
29.7
31
*
XX9TE
NOMESCO Finland
Compementary ultrasound examination
4.7
29.1
100
213
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
29.0
550
3184
WX400
NOMESCO Finland
Inhalation anesthesy
2.0
28.8
377
1915
L01EF03
ATC
abemaciclib; oral
80.3
28.7
32
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
8.1
28.4
64
79
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
22.3
27.8
40
18
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
10.0
27.6
55
55
HAD20
NOMESCO Finland
Liposuction of breast
9.4
27.5
57
61
9703
FHL
Breast resection
3.0
27.3
165
565
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
27.1
540
3173
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.6
27.0
711
4523
RD211
NOMESCO Finland
NA
1.9
27.0
411
2209
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
26.5
679
4285
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.6
26.1
382
6365
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
21.2
26.0
38
18
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
6.9
25.6
64
93
G03GA01
ATC
chorionic gonadotrophin; parenteral
2.3
25.5
240
1056
LA2AE
NOMESCO Finland
Ultrasound examination of ovarian cyst
3.9
24.7
103
266
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
9.7
24.6
50
52
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
24.5
3772
32560
XX2ET
NOMESCO Finland
NA
18.6
24.3
37
20
LAA10
NOMESCO Finland
Percutaneous or transvaginal puncture and recovery of oocyte
3.4
24.1
118
348
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
0.5
23.7
204
3926
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.4
23.6
197
815
QCJ00
NOMESCO Finland
Liposuction in upper limb
15.9
23.6
38
24
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
23.5
220
964
1DB03
NOMESCO Finland
NA
26.7
23.5
32
12
D24
ICD-10 Finland
Benign neoplasm of breast
2.2
23.3
246
1142
128
Kela drug reimbursment
Cancers of female genital organs
2.1
23.3
256
1212
N97
ICD-10 Finland
Female infertility
8.4
23.2
51
61
JN6AD
NOMESCO Finland
CT of torso and neck
3.1
23.2
127
408
OAA41
NOMESCO Finland
Health check based on individual needs
8.9
23.2
49
55
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.6
23.2
535
8053
TLW12
NOMESCO Finland
Insertion of frozen embryo
5.0
23.0
74
148
WW500
NOMESCO Finland
Blood transfusion
2.0
23.0
317
1645
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
6.0
22.7
63
106
QBA10
NOMESCO Finland
Incision of skin of trunk
3.6
22.7
103
287
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.7
22.6
437
2545
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.0
22.6
130
431
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
6.7
22.5
57
85
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
4.2
22.5
86
206
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
11.8
22.4
41
35
WF099
NOMESCO Finland
Other radiotherapy
4.7
22.4
77
166
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
5.6
22.3
65
116
HAD00
NOMESCO Finland
Augmentation mammoplasty
10.5
22.2
43
41
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
4.9
22.2
73
150
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
5.3
21.9
67
127
8211/3-C50.9
ICD-O-3
Tubular adenocarcinoma of breast, NOS
11.8
21.9
40
34
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
11.1
21.8
41
37
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.0
21.8
296
1529
8522/3-C50.2
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast
31.2
21.4
28
9
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
21.4
632
4133
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
11.1
21.3
40
36
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
4.2
21.3
81
193
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
6.1
21.2
58
96
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
21.2
610
3966
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
20.7
21.2
31
15
GA5AA
NOMESCO Finland
Rib X-ray examination
5.3
21.0
64
121
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
2.8
20.8
134
480
8507/3-C50.4
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast
24.2
20.8
29
12
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
10.6
20.8
40
38
5BA08
NOMESCO Finland
NA
4.2
20.7
78
185
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
20.7
874
11815
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.8
20.6
5836
63145
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
3.5
20.5
98
285
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
0.5
20.4
117
2561
HAA10
NOMESCO Finland
Biopsy of mammary gland
2.9
20.3
123
422
HA1AE
SPAT
NA
2.5
20.3
163
661
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
14.2
20.3
34
24
8522/3-C50.1
ICD-O-3
Infiltrating duct and lobular carcinoma of central portion of breast
32.6
20.1
26
8
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.7
20.1
485
7242
8524/3-C50.9
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of breast, NOS
27.1
20.0
27
10
D05.0
ICD-10 Finland
Lobular carcinoma in situ
5.6
20.0
58
104
L01XE07
ATC
[U] lapatinib; oral
23.4
19.9
28
12
8480/3-C50.4
ICD-O-3
Mucinous adenocarcinoma of upper-outer quadrant of breast
18.8
19.9
30
16
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
5.4
19.8
59
109
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.5
19.7
93
268
A21
ICPC
Risk factor for malignancy
7.8
19.7
45
58
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
9.8
19.5
39
40
156
Kela drug reimbursment
Lapatinib
19.4
19.5
29
15
WW200
SPAT
NA
0.6
19.4
374
5853
N64.9
ICD-10 Finland
Disorder of breast, unspecified
2.7
19.3
133
498
B01AC04
ATC
clopidogrel; oral
0.7
19.3
533
7757
HAA01
NOMESCO Finland
Suture of mammary gland
20.0
19.0
28
14
8523/3-C50.4
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast
14.0
19.0
32
23
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
19.0
579
3817
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
18.9
766
5373
P01BA02
ATC
hydroxychloroquine; oral
0.6
18.8
430
6497
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
3.3
18.8
97
300
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
9.1
18.8
39
43
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
7.2
18.7
45
63
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.6
18.7
133
508
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.4
18.6
90
266
1CD01
NOMESCO Finland
NA
6.6
18.5
47
71
C50.61
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, ductal tumor
15.0
18.4
30
20
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.2
18.4
183
831
M05BA06
ATC
ibandronic acid; systemic
1.9
18.3
270
1440
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.8
18.1
300
1665
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
5.3
18.0
55
105
1BC02
NOMESCO Finland
NA
18.0
17.7
27
15
ZZS55
NOMESCO Finland
Distension of tissue expander
22.8
17.7
25
11
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
4.1
17.5
68
167
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
17.4
694
9484
WE200
NOMESCO Finland
Profylactive therapy of malignancy with hormones
50.1
17.0
20
*
L95
ICPC
Osteoporosis
1.6
16.9
393
2420
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.3
16.9
40
55
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
6.5
16.8
43
66
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
16.8
1084
13816
SPAT1153
SPAT
Removal of sutures
1.2
16.7
2851
24600
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
4.1
16.6
64
156
NK6SN
NOMESCO Finland
Bone SPECT
15.0
16.6
27
18
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
4.8
16.6
55
116
Z2446
NOMESCO Finland
Social worker
1.6
16.3
452
2915
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
16.2
563
3822
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.2
16.2
86
274
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
4.4
16.1
58
133
Z31.6
ICD-10 Finland
General counselling and advice on procreation
5.8
16.1
45
78
WB321
NOMESCO Finland
Multiple adjuvant therapy of malignancy with biomodifiers
16.7
16.0
25
15
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
6.3
16.0
42
67
L04AA13
ATC
leflunomide; oral
0.4
15.8
66
1622
J94.8
ICD-10 Finland
Other specified pleural conditions
2.6
15.7
115
448
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.8
15.7
283
1617
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.3
15.7
45
1291
8480/3-C50.2
ICD-O-3
Mucinous adenocarcinoma of upper-inner quadrant of breast
33.4
15.7
20
6
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
12.9
15.6
27
21
TLW10
NOMESCO Finland
Transfer of fresh embryo
3.9
15.5
63
162
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.2
15.4
157
722
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
4.7
15.4
52
112
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
3.2
15.3
81
257
SPAT1324
SPAT
Screening procedure
0.8
15.3
1063
13439
SPAT1211
SPAT
Application of soft bandage
1.4
15.3
734
5315
A07EC01
ATC
sulfasalazine; oral, rectal
0.6
15.3
323
4962
W15
ICPC
Infertility/subfertility female
6.5
15.3
39
60
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.4
15.2
128
538
B04
ICPC
Blood symptom/complaint
4.1
15.2
59
146
Z2221
NOMESCO Finland
Medical doctor
1.2
15.1
2280
19380
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.2
15.1
79
249
X62
ICPC
Female Genital, Administrative procedure
45.0
15.0
18
*
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.2
15.0
147
665
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
15.0
1604
13106
C10AA05
ATC
atorvastatin; oral
0.8
14.9
2505
28786
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.5
14.9
119
485
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.6
14.9
407
2617
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.8
14.8
96
349
THA00
NOMESCO Finland
Needle biopsy of mamilla
5.3
14.7
44
83
8524/3-C50.4
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast
16.5
14.7
23
14
A08
ICPC
Swelling
1.6
14.6
374
2362
3002
Kela drug reimbursment
Ribociclib
+∞
14.6
14
*
1514
Kela drug reimbursment
NA
+∞
14.6
14
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
14.1
14.5
24
17
XX2VW
NOMESCO Finland
Radiologic consultation
3.6
14.4
65
183
E0000UV
ATC
NA
1.2
14.4
3443
30587
ZSZ00
NOMESCO Finland
Primary repair operation
8.8
14.4
30
34
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
10.0
14.4
28
28
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.7
14.4
675
9007
5702
FHL
Local lymph node removal (eg armpit, groin)
3.5
14.4
65
184
LCA06
NOMESCO Finland
Biopsy of endometrium
1.3
14.3
1307
10463
ZXD20
NOMESCO Finland
Day surgery
1.3
14.2
1092
8531
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
0.4
14.1
42
1184
S76
ICPC
Skin infection other
1.6
14.0
379
2426
C10AA01
ATC
simvastatin; oral
0.8
14.0
3046
34262
L88
ICPC
Rheumatoid/seropositive arthritis
0.5
13.9
137
2527
G03GA30
ATC
gonadotropins - combinations; systemic
12.7
13.9
24
19
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.4
13.8
115
480
8246/3-C50.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of breast, NOS
53.4
13.8
16
*
XX9XW
NOMESCO Finland
NA
3.6
13.6
61
172
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
7.6
13.6
31
41
8480/3-C50.1
ICD-O-3
Mucinous adenocarcinoma of central portion of breast
75.2
13.6
15
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
13.5
3389
30199
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
13.5
938
7225
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
13.3
193
1025
8522/3-C50.5
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast
18.2
13.3
20
11
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.8
13.3
243
1399
8460/3-C56.9
ICD-O-3
Low grade serous carcinoma of ovary
8.5
13.2
28
33
TPX15
NOMESCO Finland
Removal of vascular injection port
3.8
13.2
55
146
G03AC03
ATC
levonorgestrel; systemic
1.3
13.2
1272
10248
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.2
13.2
131
599
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
4.8
13.0
42
87
N81.1
ICD-10 Finland
Cystocele
0.7
12.9
507
6953
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.3
12.8
940
7297
N05CF02
ATC
zolpidem; oral
1.2
12.8
1562
12944
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
12.8
905
6990
N46
ICD-10 Finland
Male infertility
9.6
12.7
25
26
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
9.6
12.7
25
26
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
12.6
1013
7958
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
3.9
12.6
51
132
N97.9
ICD-10 Finland
Female infertility, unspecified
1.8
12.5
204
1134
E29.1
ICD-10 Finland
Testicular hypofunction
20.0
12.4
18
9
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.4
12.4
103
431
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
5.0
12.4
39
79
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.7
12.3
270
1637
AN1
HP
Coronary angiography
0.7
12.3
388
5519
M54.4
ICD-10 Finland
Lumbago with sciatica
0.8
12.3
919
11526
NF3AA
NOMESCO Finland
Femur X-ray examination
2.0
12.2
151
759
ZX100
NOMESCO Finland
Oral
2.4
12.2
103
437
G03GA02
ATC
human menopausal gonadotrophin; parenteral
2.0
12.0
156
799
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.5
12.0
387
2590
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
11.9
576
4179
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.2
11.9
1584
13243
8523/3-C50.2
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-inner quadrant of breast
46.7
11.9
14
*
L71
ICPC
Malignant neoplasm musculoskeletal
11.7
11.8
21
18
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
1.8
11.8
184
1006
ZX121
NOMESCO Finland
Central venous catheter
4.0
11.7
45
112
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
1.9
11.6
165
873
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
11.6
1438
17071
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
11.5
293
1852
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
0.5
11.5
100
1907
X79
ICPC
Benign neoplasm breast female
6.7
11.4
28
42
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
7.4
11.4
26
35
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.7
11.4
284
4215
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
11.3
139
699
KMAK
NOMESCO Finland
NA
0.9
11.2
3535
38831
B01AB04
ATC
dalteparin; parenteral
1.5
11.2
387
2634
PJ5YQ
NOMESCO Finland
NA
12.7
11.1
19
15
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
0.7
11.1
319
4609
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
8.5
11.0
23
27
G03GA09
ATC
corifollitropin alfa; parenteral
7.4
10.9
25
34
M05BA04
ATC
alendronic acid; oral
1.3
10.9
906
7153
L03.3
ICD-10 Finland
Cellulitis of trunk
2.9
10.9
65
228
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.8
10.9
66
234
Z31.2
ICD-10 Finland
In vitrofertilization
4.1
10.8
41
101
C10AX09
ATC
ezetimibe; oral
0.7
10.8
491
6586
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
11.9
10.8
19
16
L09
ICPC
Arm symptom/complaint
1.5
10.8
341
2271
A06AH03
ATC
naloxegol; oral
2.5
10.8
83
336
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
3.1
10.7
57
185
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
9.6
10.7
21
22
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
17.8
10.7
16
9
R06AE07
ATC
cetirizine; oral
1.2
10.6
3962
36231
C08CA01
ATC
amlodipine; oral
0.9
10.6
2399
27052
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
0.5
10.6
65
1381
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
10.5
2209
19283
Z31.1
ICD-10 Finland
Artificial insemination
5.5
10.5
30
55
L04AX01
ATC
azathioprine; systemic
0.6
10.4
119
2107
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.8
10.4
161
879
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
+∞
10.4
10
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
2.3
10.4
96
427
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
0.7
10.3
375
5212
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
10.3
2636
23395
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.8
10.3
911
11217
OAB42
SPAT
NA
0.6
10.3
124
2165
A14AB01
ATC
nandrolone; parenteral
4.6
10.2
34
74
N05CB02
ATC
barbiturates in combination with other drugs
1.5
10.2
310
2047
1XC14
NOMESCO Finland
NA
23.4
10.2
14
6
Z31.3
ICD-10 Finland
Other assisted fertilization methods
10.0
10.0
19
19
C10AA07
ATC
rosuvastatin; oral
0.8
10.0
1590
18475
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.1
10.0
4180
38494
8507/3-C50.5
ICD-O-3
Invasive micropapillary carcinoma of breast of lower-outer quadrant of breast
40.1
10.0
12
*
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.4
9.9
79
328
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
3.3
9.9
47
141
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
9.9
2961
26601
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
2.0
9.9
119
595
C50.02
ICD-10 Finland
Malignant tumor of nipple and areola, lobular tumor
12.2
9.8
17
14
L58.9
ICD-10 Finland
Radiodermatitis, unspecified
12.2
9.8
17
14
M53.1
ICD-10 Finland
Cervicobrachial syndrome
0.8
9.8
527
6898
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.5
9.7
341
2331
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.8
9.7
1370
16091
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.0
9.7
124
634
Z44.3
ICD-10 Finland
Fitting and adjustment of external breast prosthesis
13.4
9.6
16
12
8523/3-C50.5
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast
55.0
9.6
11
*
M48.0
ICD-10 Finland
Spinal stenosis
0.8
9.6
669
8476
N81.6
ICD-10 Finland
Rectocele
0.7
9.6
510
6690
SPAT1373
SPAT
Combined screening in early pregnancy
3.3
9.6
47
145
ZX050
NOMESCO Finland
Stereotactic radiotherapy
3.2
9.5
48
151
158
Kela drug reimbursment
Everolimus
8.3
9.5
20
24
I20.09
ICD-10 Finland
Unstable angina
0.6
9.5
137
2280
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
4.6
9.5
31
67
H02AB04
ATC
methylprednisolone; systemic
0.8
9.5
874
10716
J01FF01
ATC
clindamycin; systemic
1.2
9.4
2135
18736
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
4.2
9.4
34
81
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.6
9.4
137
2279
A04AA03
ATC
tropisetron; systemic
3.1
9.4
48
153
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
3.7
9.3
39
106
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
10.6
9.3
17
16
WE100
NOMESCO Finland
Profylactic cytostatic therapy
10.6
9.3
17
16
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
9.2
199
1207
HAB30
NOMESCO Finland
Excision of mamilla or areola
7.3
9.2
21
29
ZYC01
SPAT
NA
0.6
9.2
153
2468
M01CB01
ATC
sodium aurothiomalate; parenteral
0.4
9.2
37
916
X77
ICPC
Malignant neopl genital female other
3.2
9.1
46
145
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
9.1
949
11489
TQW40
NOMESCO Finland
Remowal of suture of skin
1.3
9.1
556
4198
ZXF20
NOMESCO Finland
Interruption caused by problems of surgical technique
6.7
9.1
22
33
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
6.7
9.1
22
33
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
9.0
822
6565
8097/3-C44.3
ICD-O-3
Basal cell carcinoma, nodular of skin of other and unspecified parts of face
8.3
9.0
19
23
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
3.7
9.0
37
100
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
0.7
8.9
217
3233
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.7
8.9
337
4652
TJA10
NOMESCO Finland
Laparocentesis
3.5
8.9
39
111
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.7
8.8
448
5914
I25.2
ICD-10 Finland
Old myocardial infarction
0.6
8.8
96
1714
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
0.7
8.8
322
4464
C01DA14
ATC
isosorbide mononitrate; oral
0.8
8.8
573
7319
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
1.8
8.8
145
815
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.7
8.8
165
966
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.5
8.7
64
255
L04AB01
ATC
etanercept; parenteral
0.3
8.7
18
596
L01XE10
ATC
[U] everolimus; oral
14.0
8.7
14
10
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.3
8.7
19
609
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
4.8
8.6
27
56
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.3
8.6
835
6725
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
3.8
8.6
34
89
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.8
8.6
1111
13169
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
9.0
8.5
17
19
L06
ICPC
AXILLA SYMPTOMS/COMPLAINTS
10.0
8.5
16
16
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
3.1
8.5
43
137
8522/3-C50.8
ICD-O-3
Infiltrating duct and lobular carcinoma of overlapping lesion of breast
27.5
8.5
11
*
P20
ICPC
Memory disturbance
0.8
8.5
604
7629
J05AB11
ATC
valaciclovir; oral
1.2
8.4
1090
9069
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
3.7
8.4
35
96
XX9CN
NOMESCO Finland
NA
12.7
8.4
14
11
318
Kela drug reimbursment
Teriparatide
0.1
8.3
*
319
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.0
8.3
99
496
205
Kela drug reimbursment
Chronic hypertension
0.9
8.3
1672
19086
HA3RT
NOMESCO Finland
Coagulation of mammary neoplasm under radiological guidance
8.5
8.3
17
20
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
2.9
8.3
48
166
R60.0
ICD-10 Finland
Localized oedema
1.3
8.2
874
7114
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.5
8.2
258
1724
D70.81
ICD-10 Finland
Neutropenia congenital
14.5
8.2
13
9
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
4.9
8.2
25
51
1AA01
NOMESCO Finland
NA
6.5
8.2
20
31
ZXA10
NOMESCO Finland
Bilateral
1.2
8.1
1573
13601
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
0.7
8.1
299
4139
8507/3-C50.1
ICD-O-3
Invasive micropapillary carcinoma of breast of central portion of breast
33.4
8.1
10
*
8523/3-C50.8
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of overlapping lesion of breast
33.4
8.1
10
*
Y16
ICPC
Breast symptom/complaint male
17.2
8.1
12
7
OAB47
SPAT
NA
0.4
8.0
38
883
N39.3
ICD-10 Finland
Stress incontinence
0.8
8.0
535
6812
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
3.6
8.0
34
95
N05BA04
ATC
oxazepam; oral
1.2
8.0
2081
18437
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
8.0
44
149
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.4
7.9
63
264
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
7.9
205
3013
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
2.5
7.9
58
232
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.5
7.7
57
228
HAF10
NOMESCO Finland
Repair after excision of local recurrence of breast cancer using graft or flap
45.0
7.7
9
*
1XC0V
NOMESCO Finland
NA
45.0
7.7
9
*
335
Kela drug reimbursment
Lapatinib
15.0
7.7
12
8
WE198
NOMESCO Finland
Palliative cystotatic therapy
7.4
7.7
17
23
N64.5
ICD-10 Finland
Other signs and symptoms in breast
1.6
7.6
194
1233
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
1.9
7.6
100
521
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
0.5
7.6
44
949
A10AA02
ATC
NA
0.5
7.6
55
1104
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
3.8
7.6
30
79
C10AA04
ATC
fluvastatin; oral
0.8
7.5
422
5492
N05BA06
ATC
lorazepam; systemic, sublingual
1.4
7.5
356
2584
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
2.8
7.4
44
156
X81
ICPC
Genital neopl female other/unspecif
4.8
7.4
23
48
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
0.7
7.4
259
3617
8523/3-C50.3
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-inner quadrant of breast
80.1
7.4
8
*
H05AA02
ATC
teriparatide; parenteral
0.1
7.4
*
292
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
2.8
7.4
44
157
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
13.3
7.4
12
9
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
3.9
7.3
28
72
L01EF02
ATC
ribociclib; oral
+∞
7.3
7
*
N03AG01
ATC
valproic acid; systemic, rectal
0.7
7.3
187
2751
N64.8
ICD-10 Finland
Other specified disorders of breast
2.5
7.3
52
207
OAB44
SPAT
NA
0.6
7.3
86
1501
TLW14
NOMESCO Finland
ICSI
4.5
7.2
24
54
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.5
7.2
61
1167
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
4.2
7.2
25
59
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
0.6
7.2
152
2319
00044
NOMESCO Finland
NA
30.0
7.1
9
*
8523/3-C50.1
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of central portion of breast
30.0
7.1
9
*
8503/3-C50.9
ICD-O-3
Intraductal papillary adenocarcinoma with invasion of breast, NOS
30.0
7.1
9
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.2
7.1
68
310
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
1.8
7.1
121
689
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
0.7
7.1
177
2622
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
6.5
7.1
17
26
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
7.1
1918
17031
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
3.6
7.0
29
80
ZX002
NOMESCO Finland
Simple dose design for radiotherapy based on tomography - isocentric therapy
10.0
7.0
13
13
N06AX11
ATC
mirtazapine; oral
1.1
7.0
2667
24245
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.3
7.0
476
3662
AN4
HP
Balloon angioplasty and drug eluding stent
0.5
7.0
48
980
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
2.4
7.0
56
237
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
5.8
6.9
18
31
8211/3-C50.4
ICD-O-3
Tubular adenocarcinoma of upper-outer quadrant of breast
7.5
6.9
15
20
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
13.8
6.9
11
8
N06AA09
ATC
amitriptyline; systemic
0.8
6.8
644
7886
Z31.4
ICD-10 Finland
Procreative investigation and testing
3.8
6.8
27
72
R07.4
ICD-10 Finland
Chest pain, unspecified
0.9
6.8
1803
20206
SPAT1059
SPAT
Spirometry at the office
0.7
6.8
204
2918
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
3.3
6.8
31
93
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
5.0
6.8
20
40
WB213
NOMESCO Finland
Adjuvant hormone therapy of malignancy
40.0
6.8
8
*
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
1.6
6.8
175
1122
ZZR70
NOMESCO Finland
Perforator flaps
16.7
6.7
10
6
C507
ICD-10 Finland
NA
7.1
6.7
15
21
SPAT1255
SPAT
Intravenous administration of medicine
1.3
6.7
415
3148
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
1.9
6.7
90
475
8931/3-C54.1
ICD-O-3
Endometrial stromal sarcoma, low grade of endometrium
22.5
6.7
9
*
C50.62
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, lobular tumor
22.5
6.7
9
*
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.2
6.6
1790
15879
8140/3-C50.9
ICD-O-3
Adenocarcinoma, NOS, of breast, NOS
4.9
6.6
20
41
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
1.4
6.6
316
2299
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
0.7
6.6
273
3709
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
2.3
6.6
57
251
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
3.2
6.5
31
96
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.2
6.5
31
96
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
4.8
6.5
20
42
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.8
6.5
361
4701
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
2.8
6.5
38
135
ZXC82
NOMESCO Finland
Microsurgical
6.2
6.4
16
26
C54.22
ICD-10 Finland
Endometrial stromal cell sarcoma
6.2
6.4
16
26
A55
ICPC
General and Unspecified, Local injection/infiltration
2.2
6.4
58
259
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.5
6.4
211
1427
8522/3-C50.3
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-inner quadrant of breast
69.9
6.4
7
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
0.7
6.4
156
2315
340
Kela drug reimbursment
Everolimus
14.3
6.4
10
7
L04AB04
ATC
adalimumab; parenteral
0.4
6.4
32
723
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
0.6
6.3
132
2020
L04AA06
ATC
mycophenolic acid; systemic
0.4
6.3
23
590
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
0.7
6.3
240
3298
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
0.7
6.3
284
3805
PJW20
NOMESCO Finland
Lymphovenous shunt
11.0
6.3
11
10
S21.9
ICD-10 Finland
Open wound of thorax, part unspecified
5.5
6.3
17
31
ZZR00
NOMESCO Finland
Flap of skin
1.6
6.3
146
914
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
0.7
6.3
209
2937
N95
ICD-10 Finland
Menopausal and other perimenopausal disorders
0.6
6.3
89
1483
9702
FHL
Breast exploration and possible tumor removal
1.6
6.3
168
1087
M907, C5041
ICD-10 Finland
NA
+∞
6.2
6
*
C504, C5041
ICD-10 Finland
NA
+∞
6.2
6
*
8507/3-C50.3
ICD-O-3
Invasive micropapillary carcinoma of breast of lower-inner quadrant of breast
+∞
6.2
6
*
3AF02
NOMESCO Finland
NA
+∞
6.2
6
*
8507/3-C50.8
ICD-O-3
Invasive micropapillary carcinoma of breast of overlapping lesion of breast
+∞
6.2
6
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
0.6
6.2
109
1732
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.9
6.2
1592
17893
L03
ICPC
Low back symptom/complaint
0.9
6.2
1653
18533
8541/3-C50.9
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of breast, NOS
26.7
6.2
8
*
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
26.7
6.2
8
*
HAA00
NOMESCO Finland
Incision of mammary gland
4.3
6.2
21
49
ULC02
NOMESCO Finland
Hysteroscopy
1.3
6.2
514
4067
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
2.2
6.1
56
252
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.8
6.1
554
6811
N02AA01
ATC
morphine; systemic, rectal
2.1
6.1
61
285
A03FA02
ATC
cisapride; oral, rectal
0.8
6.1
435
5493
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.2
6.1
686
5623
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
0.7
6.1
241
3294
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
1.9
6.1
77
397
RF210
NOMESCO Finland
NA
1.5
6.1
195
1319
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
3.6
6.1
25
70
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
6.1
84
1405
R96
ICPC
Asthma
0.8
6.0
490
6096
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
8.6
6.0
12
14
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.3
6.0
50
216
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
673
947
7.47
307.65
1.7
1.3
nmol/l
0.3
0.3
0.15
401
653
(3002256) Pathology report gross observation
3476
13552
3.20
307.65
1.3
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
7262
49341
2.18
307.65
3.7
3.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
5535
33529
2.20
307.65
2.1
2.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
9573
56009
4.39
307.65
10.4
5.5
umol/l
9.4
10.5
24.30
9396
52553
(40768804) Tissue Pathology biopsy report
7030
46592
2.21
307.65
2.4
2.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
2824
2574
14.00
307.65
1.4
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
2913
1563
24.22
307.65
4.7
2.3
u/ml
44.8
32.0
2.32
2825
1506
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
3355
11748
3.57
307.65
4.4
3.7
ug/l
14.4
21.7
1.42
2670
9394
(1617658) Protocol used for examination of sentinel lymph nodes
1469
591
28.15
307.65
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
5202
27106
2.61
307.65
9.9
6.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
7036
39645
2.85
307.65
6.8
3.0
mmol/l
2.4
2.4
68.04
6492
33731
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
1051
2821
3.98
307.65
1.2
1.3
—
—
—
0
0
(4035726)
4138
9167
6.34
307.65
1.4
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
1754
1035
19.65
307.65
5.2
2.3
u/ml
58.4
40.0
2.25
1741
1016
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
11252
84215
5.75
307.65
12.8
7.1
u/l
80.4
78.6
3.94
11070
78306
(3013650) Neutrophils [#/volume] in Blood by Automated count
9423
61118
3.44
307.65
13.7
8.9
e9/l
3.5
4.0
137.31
8744
52792
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
730
473
16.36
307.65
1.1
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
7808
57592
2.00
275.31
7.1
6.0
mmol/l
1.2
1.2
36.35
6413
48385
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
7180
52269
1.92
253.14
5.6
5.4
mmol/l
1.2
1.2
53.82
6732
46639
(40768795) Lymph node Pathology biopsy report
509
1043
5.05
232.84
1.1
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
399
690
5.95
219.81
1.2
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1872
8887
2.31
213.65
4.7
3.9
u/ml
57.5
62.5
0.32
1815
8563
(3023368) Bacteria identified in Blood by Culture
4002
26053
1.80
183.43
3.9
4.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1902
9983
2.07
165.17
1.7
2.1
g/l
0.2
0.2
28.51
1831
9267
(3018418) pH of Serum or Plasma
4943
35059
1.69
161.64
4.8
3.8
ph
7.4
7.4
6.66
1285
6113
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
465
1190
4.02
160.08
1.4
1.3
u/l
40.1
40.8
0.13
434
942
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3849
25701
1.73
155.85
2.1
2.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
298
619
4.91
133.79
2.0
1.6
ug/l
5.1
6.6
0.41
218
435
(3023323) Follitropin [Units/volume] in Serum or Plasma
823
3345
2.57
129.54
1.5
1.3
iu/l
44.1
39.0
3.60
714
2888
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
6450
50911
1.57
124.16
2.3
2.3
nmol/l
83.0
1903.3
0.50
5987
44991
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1674
9388
1.91
117.00
4.5
3.4
mmol/l
1.2
1.2
7.47
1565
7993
(3024561) Albumin [Mass/volume] in Serum or Plasma
6135
48492
1.54
112.77
3.9
4.4
g/l
35.5
35.5
0.19
5736
44581
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
557
2026
2.83
108.79
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
10947
100796
1.90
92.06
19.0
13.1
ml/min/173m2
79.3
77.5
21.92
9964
81885
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
11283
105176
2.07
88.19
17.6
14.1
mg/l
21.8
21.7
0.14
9447
82846
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
397
1355
3.00
86.92
1.2
1.2
u/l
60.7
58.2
0.50
250
914
(40758358) Immune stain study
70
41
17.17
85.01
1.0
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
355
1185
3.06
80.80
1.5
1.2
u/l
15.8
20.0
4.31
306
973
(3042936) Bacteria identified in Isolate by Culture
2074
13941
1.59
72.49
1.8
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
3432
25972
1.45
67.30
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
1785
12000
1.57
61.34
4.8
4.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
211
627
3.41
58.23
1.2
1.1
u/l
73.3
82.4
1.02
191
479
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
211
630
3.39
57.80
1.2
1.1
u/l
18.4
23.5
0.78
189
466
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2981
22569
1.43
56.36
3.0
3.0
mmol/l
2.5
2.5
15.14
2676
19667
(3017446) Testosterone [Moles/volume] in Serum or Plasma
221
690
3.24
56.35
3.1
1.6
nmol/l
9.5
6.4
3.62
204
572
(3019550) Sodium [Moles/volume] in Serum or Plasma
11551
110544
1.97
53.79
18.0
16.2
mmol/l
139.7
139.8
1.23
11372
107607
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11682
112301
2.14
52.86
16.5
10.8
u/l
24.6
23.8
4.20
11533
107645
(3033658) Prothrombin time (PT) actual/Normal
3463
27150
1.39
52.74
3.4
3.7
%
95.1
94.4
0.82
3376
26406
(3023103) Potassium [Moles/volume] in Serum or Plasma
11556
110754
1.95
51.33
18.1
16.4
mmol/l
3.9
3.9
2.42
11360
107621
(3001556) Androgen free Index in Serum or Plasma
44
28
15.77
51.14
1.5
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1580
10802
1.53
49.46
3.4
3.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
227
804
2.86
46.54
1.6
1.5
u/l
5.5
5.8
0.11
114
370
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2202
16605
1.40
40.57
1.7
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
337
1586
2.16
37.45
3.1
2.0
u/l
3203.5
4638.2
0.70
216
682
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
205
785
2.64
36.26
1.2
1.2
u/l
13.3
23.4
4.51
183
663
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
205
800
2.59
34.91
1.2
1.2
u/l
64.1
84.6
3.98
187
698
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
43
53
8.14
32.42
1.4
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
249
1109
2.27
31.74
1.6
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3968
33644
1.27
30.42
4.2
3.1
u/l
36.8
32.7
1.23
3774
31731
(3032080) INR in Blood by Coagulation assay
4877
42405
1.25
29.96
7.8
7.9
inr
1.2
1.2
0.48
1492
11842
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
45
67
6.74
28.81
1.7
1.1
nmol/l
0.1
0.2
2.68
23
36
(3002385) Erythrocyte distribution width [Ratio]
9201
86321
1.27
27.10
23.5
17.3
%
13.8
13.7
7.86
9116
84395
(3013826) Glucose [Moles/volume] in Serum or Plasma
6846
62160
1.23
27.01
3.8
4.3
mmol/l
6.6
6.6
2.25
6478
57988
(3013512) EKG study
3860
32994
1.25
26.69
4.0
3.9
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
49
87
5.65
26.39
1.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
8243
76463
1.24
26.16
3.8
3.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
4247
36956
1.23
24.27
4.6
6.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
11228
108721
1.45
24.09
16.9
13.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
463
2793
1.68
24.05
1.5
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
649
4274
1.55
23.49
1.8
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
377
2169
1.76
23.24
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
377
2169
1.76
23.24
1.2
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
9676
100942
0.79
21.29
3.8
4.1
mmol/l
1.3
1.3
4.52
8534
90849
(3007461) Platelets [#/volume] in Blood
11787
115608
1.74
21.00
28.8
21.2
e9/l
258.9
261.6
4.98
11631
112099
(40768806) Pleura Pathology biopsy report
184
862
2.15
20.87
1.5
1.5
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
107
392
2.75
20.84
1.2
1.3
umol/l
5.0
3.5
3.33
100
358
(3035941) MCH [Entitic mass]
11787
115649
1.72
20.41
28.7
21.1
pg
30.4
30.2
37.89
11720
113706
(3024731) MCV [Entitic volume]
11787
115660
1.72
20.25
28.7
21.1
fl
92.0
91.2
72.46
11720
113722
(3026361) Erythrocytes [#/volume] in Blood
11787
115666
1.72
20.16
28.8
21.2
e12/l
4.3
4.4
83.63
11619
111751
(3010813) Leukocytes [#/volume] in Blood
11787
115674
1.71
20.05
28.8
21.2
e9/l
6.2
6.6
61.38
11615
111779
(3000963) Hemoglobin [Mass/volume] in Blood
11787
115686
1.71
19.88
28.9
21.3
g/l
129.9
131.8
56.48
11721
113782
(3019069) Monocytes/100 leukocytes in Blood
5532
50068
1.19
19.52
5.1
6.5
%
8.6
8.4
2.09
5172
46491
(3002030) Lymphocytes/100 leukocytes in Blood
5637
51114
1.19
19.45
5.0
6.3
%
26.9
28.6
24.09
5228
47193
(3021589) Normoblasts [#/volume] in Blood
5262
47428
1.19
19.41
11.4
9.4
e9/l
0.0
0.0
1.53
4323
38687
(3004809) Band form neutrophils/100 leukocytes in Blood
291
1638
1.80
19.39
2.0
3.4
%
2.5
1.3
4.26
213
1286
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
586
3935
1.51
19.38
1.7
1.8
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
216
1107
1.97
19.25
1.4
1.4
g/l
35.9
32.7
3.70
199
1009
(3052851) Hemolysis interference index of Serum or Plasma
507
3318
1.55
18.89
2.6
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1741
21333
0.79
18.52
1.3
1.3
iu/ml
35.1
38.4
0.31
528
6910
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
10115
104716
0.79
18.44
4.3
4.7
mmol/l
1.6
1.6
1.16
9037
95188
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
10452
107786
0.78
18.44
4.9
5.3
mmol/l
2.9
2.8
1.51
9342
98131
(3006504) Eosinophils/100 leukocytes in Blood
5487
49813
1.19
18.19
4.9
6.2
%
2.7
2.8
5.26
5101
46018
(3019150) Specific gravity of Urine by Refractometry
1991
23920
0.80
17.73
4.1
4.7
kg/l
1.0
1.0
1.00
335
3682
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1660
20361
0.79
17.71
1.2
1.3
u/ml
9.6
14.5
2.42
576
7439
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
152
706
2.17
17.70
1.6
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
10218
105545
0.80
17.21
4.3
4.7
mmol/l
4.9
4.9
2.28
9198
96474
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1444
11488
1.29
17.19
1.7
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1508
12076
1.28
17.04
1.6
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
9607
99862
0.82
17.00
5.5
5.9
mmol/mol
39.6
39.7
0.10
8673
91333
(3050129) First trimester maternal screen panel - Serum or Plasma
209
1119
1.88
16.43
1.6
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
354
2207
1.62
16.26
1.4
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
364
2293
1.61
16.03
1.4
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1261
15819
0.77
15.99
1.3
1.4
titre
565.0
585.2
0.14
271
3714
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
283
1679
1.70
15.76
1.4
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1429
11475
1.28
15.73
1.7
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
2810
24278
1.20
15.68
1.4
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
129
592
2.19
15.54
2.2
3.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2080
17487
1.23
15.24
3.2
3.0
mmol/l
0.8
0.8
1.01
1934
16105
(3022096) Basophils/100 leukocytes in Blood
5295
48454
1.16
14.66
4.9
6.2
%
0.7
0.7
0.07
4925
44756
(40761535) Cells panel - Urine sediment
699
9368
0.73
14.13
3.4
3.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1952
16422
1.22
14.11
2.6
2.8
e6/l
3.8
4.6
1.76
961
8478
(3012441) Differential panel - Pleural fluid
160
826
1.95
14.10
1.4
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
5490
50485
1.16
14.00
4.8
6.1
%
57.5
56.7
4.01
5107
46770
(3031040) Bacteria [#/volume] in Urine by Automated count
7842
74083
1.17
13.91
4.9
5.0
e6/l
467.3
2642.6
9.97
81
903
(3009542) Hematocrit [Volume Fraction] of Blood
9645
92737
1.20
13.59
20.1
15.6
%
38.7
38.7
0.24
6719
62929
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3053
34365
0.85
12.81
1.9
2.1
u/l
174.2
167.2
0.15
2819
31934
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
819
6282
1.33
12.66
1.6
1.7
—
—
—
0
0
(4034850)
235
3797
0.61
12.51
12.0
9.8
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
182
1020
1.80
12.48
1.4
1.4
e6/l
4736.9
2813.6
0.24
132
746
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
99
452
2.20
12.18
1.8
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1132
9145
1.26
11.73
2.9
4.1
%
1.8
0.9
10.88
447
2388
(3048689) Calprotectin [Mass/mass] in Stool
1118
13733
0.80
11.63
2.0
2.0
ug/g
119.3
128.1
0.39
842
10463
(3002582) Erythrocytes [#/volume] in Urine
3479
31260
1.16
11.45
2.9
3.1
e6/l
60.1
64.0
0.09
2553
23348
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
191
3162
0.60
11.27
1.6
1.6
iu/ml
0.1
10.4
0.98
47
693
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1191
9727
1.25
11.22
2.4
3.3
ng/l
70.2
82.3
9.57
1032
8189
(3028308) Erythrocytes [#/volume] in Pleural fluid
163
919
1.78
11.01
1.4
1.4
e6/l
31857.2
48236.0
0.57
92
528
(3026493) Urate [Moles/volume] in Serum or Plasma
2351
26752
0.85
10.94
2.2
2.4
umol/l
5481.2
4811.5
0.29
1969
22628
(3036782) Glucose [Moles/volume] in Pleural fluid
139
749
1.87
10.88
1.3
1.3
mmol/l
6.3
6.5
0.44
130
704
(3045788) Cell count panel - Pleural fluid
144
790
1.83
10.66
1.5
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
134
723
1.86
10.46
1.3
1.3
u/l
458.5
364.7
0.28
128
686
(36304419) Bacteria [Presence] in Urine
3172
28499
1.15
10.22
2.8
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3243
29199
1.15
10.13
2.8
3.1
e6/l
0.6
0.4
1.45
2346
21632
(3026782) Osmolality of Urine
2297
20222
1.17
9.64
2.5
2.7
mosm/kgh2o
504.1
501.6
0.23
1958
16975
(3020682) Albumin/Creatinine [Ratio] in Urine
3049
33737
0.87
9.48
3.6
3.8
mg/mmol
7.2
7.5
0.10
1622
18838
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
165
978
1.70
9.42
1.3
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
201
1255
1.61
9.37
1.4
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
366
5071
0.71
9.12
1.2
1.3
u/ml
1.1
1.1
0.02
29
465
(3026008) Bacteria identified in Urine by Culture
4356
40217
1.13
9.05
3.3
3.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
139
795
1.76
9.03
1.1
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
2901
32125
0.87
9.03
2.9
3.1
mg/l
331.3
492.6
1.04
1562
17839
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
500
3758
1.34
8.95
1.9
1.9
ug/l
2.1
2.0
0.03
435
3302
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
172
1054
1.64
8.69
1.3
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
193
1218
1.59
8.65
2.5
3.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1010
8343
1.23
8.54
2.9
4.0
%
1.3
0.6
7.80
305
1723
(3021440) Promyelocytes/100 leukocytes in Blood
1052
8736
1.22
8.45
3.0
4.2
%
0.3
0.1
4.27
404
2206
(3005719) IgG [Mass/volume] in Serum or Plasma
641
8075
0.78
8.22
2.7
3.0
g/l
10.2
10.3
0.23
576
7370
(40761536) Microorganisms panel - Urine sediment
1079
9014
1.22
8.17
4.4
4.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
214
3202
0.66
8.16
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3790
41064
0.89
8.15
4.1
4.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
3026
33162
0.88
7.77
2.8
3.0
mmol/l
6.4
6.2
0.91
2440
27527
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
102
559
1.83
7.71
1.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
102
559
1.83
7.71
1.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
102
559
1.83
7.71
1.3
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
292
2061
1.43
7.70
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
691
8556
0.80
7.65
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
128
753
1.71
7.61
1.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
102
562
1.82
7.59
1.3
1.7
—
—
—
0
0
(4010399)
708
8732
0.80
7.57
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
147
899
1.64
7.55
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
147
899
1.64
7.55
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
147
899
1.64
7.55
1.3
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
996
8321
1.21
7.54
1.5
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
164
1032
1.60
7.50
1.5
1.5
—
—
—
0
0
(3010421) pH of Blood
352
2578
1.38
7.50
3.3
3.4
ph
7.4
7.4
0.96
291
2130
(3005322) IgE [Units/volume] in Serum or Plasma
532
6772
0.78
7.43
1.3
1.3
u/ml
179.3
176.8
0.03
481
6204
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
387
2882
1.35
7.43
1.7
2.1
%
95.5
94.2
0.48
348
2661
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
153
950
1.62
7.40
1.1
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
367
2712
1.36
7.40
1.8
2.4
%
197.6
193.1
0.41
351
2546
(3018095) Leukocytes [#/volume] in Urine
4073
37799
1.12
7.32
3.4
3.7
e6/l
113.3
117.2
0.11
2732
25588
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
31
104
2.99
7.32
1.4
3.0
mg/l
0.8
1.2
1.43
16
75
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
713
5775
1.25
7.25
1.4
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
10325
105370
0.86
7.23
4.6
4.9
mmol/l
5.9
5.9
1.68
9201
95364
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
363
2699
1.36
7.06
1.8
2.4
g/l
3.6
3.6
0.15
354
2560
(3011397) Hemoglobin [Presence] in Urine by Test strip
2471
27269
0.88
6.97
3.4
4.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
301
2177
1.39
6.95
3.5
3.5
mmol/l
2.6
2.8
0.64
215
1584
(3013290) Carbon dioxide [Partial pressure] in Blood
301
2178
1.39
6.93
3.5
3.5
kpa
5.0
5.1
0.55
290
2131
(3017354) Segmented neutrophils/100 leukocytes in Blood
163
1052
1.56
6.74
2.2
3.4
%
56.4
58.5
0.49
95
693
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
8718
89814
0.90
6.68
4.5
4.7
pmol/l
15.0
14.9
0.49
7792
81415
(3013707) Erythrocyte sedimentation rate by Westergren method
8045
83215
0.90
6.58
3.6
4.5
mm/h
15.0
13.5
14.20
7275
76623
(40767503) Oxygen content in Capillary blood by calculation
287
2082
1.39
6.54
2.3
2.5
%
15.9
15.9
0.03
129
1062
(3027315) Oxygen [Partial pressure] in Blood
301
2201
1.38
6.53
3.5
3.6
kpa
8.6
8.6
0.15
290
2154
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1286
14791
0.85
6.52
7.0
6.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
82
444
1.85
6.51
1.4
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
82
444
1.85
6.51
1.4
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
314
2316
1.37
6.46
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
527
4184
1.27
6.40
2.7
3.3
u/ml
1240.6
1085.9
0.07
423
3525
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
153
988
1.56
6.34
1.6
1.8
ug/l
18.4
25.8
1.55
148
968
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
82
452
1.82
6.18
1.4
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
275
3733
0.73
6.15
1.7
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
732
8797
0.82
6.12
2.0
2.3
ug/l
3.9
5.8
6.55
606
7486
(4281824)
260
1881
1.39
6.05
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
19
53
3.59
6.02
2.0
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2640
24149
1.12
5.92
1.6
1.7
mg/l
1.3
1.2
0.86
2048
18641
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
250
1810
1.39
5.81
1.5
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
702
5818
1.22
5.81
4.5
6.2
mmol/l
25.2
25.1
0.21
692
5767
(3024869) Neuronal Ab [Presence] in Serum
40
173
2.32
5.81
1.1
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
118
736
1.61
5.71
1.4
1.6
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
47
221
2.13
5.60
1.3
1.4
%
11.2
20.3
2.37
40
207
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
281
0.21
5.60
1.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
264
1947
1.36
5.51
1.6
1.7
mu/l
279.8
348.4
1.33
250
1741
(3008757) Leukocyte morphology finding [Identifier] in Blood
167
1138
1.47
5.44
2.2
3.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
20
62
3.23
5.43
1.1
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
94
562
1.68
5.40
1.2
1.3
u/l
12.1
11.4
0.17
87
507
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
327
4222
0.77
5.20
1.5
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
78
448
1.75
5.19
1.3
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
485
3922
1.25
5.10
1.6
1.4
pmol/l
156.2
176.5
0.52
473
3827
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
29
116
2.50
5.02
1.4
1.3
%
9.4
15.7
0.94
17
60
(3035350) Ketones [Presence] in Urine by Test strip
5185
54384
0.92
4.98
3.8
4.1
estimate
0.0
0.0
0.80
1075
9747
(3028026) IgM [Mass/volume] in Serum or Plasma
519
6309
0.81
4.92
1.7
1.9
g/l
1.3
1.3
0.24
459
5690
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
271
3559
0.76
4.91
1.5
1.6
g/l
1.2
1.2
0.69
255
3369
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
262
3456
0.75
4.90
1.5
1.7
g/l
0.2
0.2
0.97
245
3255
(21494755) Public health laboratory ask at order entry panel
516
6270
0.82
4.87
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
87
527
1.66
4.80
1.6
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
31
131
2.37
4.79
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
218
2943
0.74
4.79
1.4
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
32
138
2.32
4.74
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2245
24430
0.90
4.72
1.6
1.7
pmol/l
35358022.3
33957859.1
0.04
1762
19763
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
279
3628
0.76
4.72
1.2
1.3
u/ml
10.5
45.7
6.03
12
234
(3036489) Thrombin time
454
3681
1.24
4.70
1.6
1.9
s
22.2
21.5
0.69
392
3212
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
253
3330
0.75
4.68
1.2
1.3
u/ml
7.4
7.3
0.02
36
603
(3029937) Albumin [Presence] in Urine by Test strip
2731
29399
0.91
4.61
4.2
4.7
estimate
0.0
0.0
2.57
1071
9779
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
138
939
1.48
4.60
1.4
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
250
3285
0.76
4.58
1.2
1.3
u/ml
2.1
4.7
1.52
17
381
(3001893) Eosinophils/100 leukocytes in Pleural fluid
47
240
1.96
4.56
1.4
1.3
%
1.4
3.2
1.63
39
206
(3013115) Eosinophils [#/volume] in Blood
5792
55509
1.08
4.54
4.8
6.1
e9/l
0.2
0.2
10.83
4935
48339
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
138
942
1.47
4.53
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4252
44846
0.92
4.51
2.6
2.8
ug/l
144.0
111.1
7.72
3864
40972
(3025468) Yersinia sp identified in Specimen by Organism specific culture
212
1563
1.36
4.51
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
138
943
1.47
4.51
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
138
943
1.47
4.51
1.4
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
87
538
1.62
4.46
1.6
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
358
4472
0.79
4.40
1.6
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
211
1562
1.36
4.39
1.3
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
53
287
1.85
4.34
1.4
1.3
%
71.7
61.9
1.59
45
242
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
16
50
3.20
4.33
1.8
1.3
pmol/l
35.9
19.1
—
7
17
(3005988) Vibrio sp identified in Specimen by Organism specific culture
211
1566
1.35
4.32
1.3
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
475
5737
0.82
4.26
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
606
5112
1.20
4.25
1.3
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
667
7799
0.85
4.18
2.4
2.4
au/ml
21.6
30.4
0.80
26
376
(3024522) Salmonella sp identified in Specimen by Organism specific culture
212
1584
1.34
4.17
1.3
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
92
587
1.57
4.17
1.6
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
68
1117
0.61
4.16
1.1
1.1
—
1.5
—
0
22
(3025159) Blasts/100 leukocytes in Blood
945
8279
1.15
4.16
3.1
4.2
%
0.4
0.4
0.05
328
1892
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
43
221
1.95
4.13
1.2
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
182
1330
1.37
4.13
1.1
1.1
%
127.4
124.3
0.66
164
1179
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
211
1579
1.34
4.12
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
388
3143
1.24
4.10
2.4
2.9
u/ml
0.4
0.4
1.18
235
1826
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
991
8727
1.15
4.06
3.9
2.6
ml/min/173m2
64.7
62.6
1.23
421
3506
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
281
3571
0.78
4.03
1.4
1.6
titre
67.2
282.7
—
9
186
(3000330) Specific gravity of Urine by Test strip
498
5952
0.83
4.02
4.1
3.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
4545
47646
0.93
4.00
1.9
2.0
pmol/l
99.1
99.6
0.28
2092
21825
(3020961) Endomysium IgA Ab [Titer] in Serum
419
5088
0.82
3.99
1.1
1.1
titre
534.0
210.8
—
5
111
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
144
1020
1.42
3.94
1.4
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2471
26548
0.91
3.92
2.2
2.3
mg/l
3.0
3.0
0.37
2088
22586
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
26
558
0.46
3.90
1.0
1.1
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
33
158
2.09
3.86
1.3
1.4
mu/l
502.6
497.7
0.01
33
150
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
174
1278
1.37
3.86
1.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
225
1720
1.31
3.82
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
565
6640
0.84
3.79
2.4
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1983
21488
0.91
3.77
1.7
1.7
nmol/l
1148.4
1197.7
1.48
1407
15929
(3021601) Nitrite [Presence] in Urine by Test strip
5272
54879
0.93
3.75
5.1
5.5
estimate
0.0
0.0
1.84
1079
9763
(3009445) Proteinase 3 Ab [Units/volume] in Serum
379
4616
0.82
3.74
1.4
1.5
u/ml
29.5
15.5
—
9
108
(3042733) HLA Ab [Presence] in Serum
6
223
0.27
3.73
4.7
4.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
213
1622
1.32
3.73
1.3
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
300
2391
1.26
3.69
2.8
3.2
u/ml
174.2
907.2
2.30
275
2155
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
33
161
2.05
3.69
1.3
1.4
%
71.6
73.4
0.29
33
153
(3003338) MCHC [Mass/volume]
8427
86218
0.93
3.69
25.2
18.9
g/l
330.0
330.3
1.95
8392
85632
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1985
18310
1.10
3.67
2.5
2.6
e6/l
3.0
1.4
0.50
990
10276
(3019198) Lymphocytes [#/volume] in Blood
5694
54812
1.07
3.66
4.8
6.0
e9/l
1.7
1.9
26.90
4856
47900
(3009261) Glucose [Presence] in Urine by Test strip
5331
55432
0.93
3.64
3.9
4.2
estimate
0.0
0.0
0.06
1087
9855
(3024980) IgG subclass 4 [Mass/volume] in Serum
123
1732
0.71
3.62
1.3
1.5
g/l
0.6
0.6
0.24
85
1301
(3015736) pH of Urine
4034
42364
0.93
3.62
3.4
3.9
ph
5.6
5.9
—
6
13
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
50
852
0.59
3.60
1.3
1.2
—
195.3
—
0
32
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
9
17
5.30
3.50
10.4
4.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
9
17
5.30
3.50
5.2
2.5
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
6
6
10.00
3.49
1.2
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
51
855
0.59
3.46
1.3
1.2
titre
227.0
194.3
—
10
159
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
123
1714
0.71
3.42
1.3
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
209
2693
0.77
3.41
1.2
1.2
u/ml
23.4
50.4
3.69
21
312
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
31
595
0.52
3.40
1.1
1.1
u/ml
2.3
6.3
—
5
74
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
614
7099
0.86
3.39
1.2
1.3
au/ml
56.0
50.6
0.17
26
291
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
77
1167
0.66
3.38
1.1
1.0
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
53
312
1.70
3.37
6.7
2.9
ng/l
101.5
126.5
0.24
28
88
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
10104
102474
0.92
3.21
5.3
5.6
mu/l
2.0
2.1
1.17
9112
93592
(3006315) Basophils [#/volume] in Blood
5575
53782
1.07
3.21
4.7
6.0
e9/l
0.0
0.0
2.99
4692
46073
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
283
2283
1.25
3.19
2.0
2.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
106
1493
0.71
3.17
1.1
1.2
u/l
32.8
35.8
0.15
87
1301
(44790047)
138
1012
1.37
3.16
1.2
1.4
—
—
—
0
0
(44790049)
138
1012
1.37
3.16
1.2
1.4
—
—
—
0
0
(44806118)
138
1012
1.37
3.16
1.2
1.4
—
—
—
0
0
(44790048)
138
1012
1.37
3.16
1.2
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
6774
65787
1.07
3.15
3.0
3.0
u/l
57.4
44.9
11.22
6246
60269
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
134
1813
0.74
3.13
2.1
1.6
nmol/l
0.9
0.8
0.99
115
1489
(3001604) Monocytes [#/volume] in Blood
5546
53522
1.07
3.12
4.7
6.0
e9/l
0.5
0.6
2.21
4665
45874
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2355
25123
0.92
3.10
1.2
1.3
u/ml
1.5
1.5
0.03
537
6415
(3000475) Leukocytes [#/volume] in Synovial fluid
226
2846
0.79
3.09
1.5
1.7
e6/l
18748.4
11612.7
0.97
165
2057
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
782
8824
0.88
3.08
1.5
1.6
%
1.4
1.4
0.21
672
7559
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
179
1372
1.31
3.06
1.4
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
72
1081
0.66
3.05
1.3
1.5
e6/l
188031.5
111766.7
0.36
50
727
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
106
1481
0.71
3.04
1.4
1.6
%
54.6
54.6
0.00
66
893
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
98
686
1.43
2.97
3.1
2.7
ug/l
1.3
1.5
0.36
72
461
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
90
621
1.45
2.94
1.5
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
68
444
1.53
2.90
2.5
2.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
63
405
1.56
2.88
1.0
1.0
%
98.8
95.3
0.47
50
301
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
218
2731
0.79
2.88
1.2
1.3
u/ml
1.0
5.9
—
10
215
(4306422)
179
1386
1.30
2.87
1.1
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
177
2269
0.78
2.84
1.3
1.5
e6/l
418.0
1914.4
2.44
133
1855
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
177
2267
0.78
2.82
1.3
1.4
e6/l
8.2
35.0
2.88
122
1755
(40763480) Human metapneumovirus Ag [Presence] in Specimen
13
47
2.77
2.81
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
109
787
1.39
2.79
1.7
1.6
umol/l
5.6
8.1
0.71
82
570
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
188
1471
1.28
2.79
1.4
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
116
1571
0.74
2.78
1.3
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
78
1128
0.69
2.76
1.2
1.4
g/l
6.3
6.8
0.61
49
790
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
242
2980
0.81
2.75
1.1
1.1
u/ml
2.2
8.9
4.03
29
283
(3028192) IgG subclass 2 [Mass/volume] in Serum
78
1127
0.69
2.75
1.2
1.4
g/l
2.6
2.8
0.46
49
789
(3046861) Legionella sp Ag [Presence] in Urine
12
42
2.86
2.74
1.2
1.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
78
1126
0.69
2.74
1.2
1.4
g/l
0.4
0.4
0.37
49
789
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
37
210
1.76
2.73
1.2
1.3
ug/l
762.9
234.4
0.58
30
125
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
469
5431
0.86
2.71
1.8
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
239
2940
0.81
2.70
2.4
2.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
73
1062
0.69
2.68
1.5
1.5
%
33.6
34.1
0.03
39
611
(3014599) Egg white IgE Ab [Units/volume] in Serum
24
459
0.52
2.68
1.0
1.0
u/ml
0.6
1.0
—
5
111
(3008401) Mugwort IgE Ab [Units/volume] in Serum
91
1272
0.71
2.67
1.0
1.1
u/ml
2.2
0.9
0.40
33
469
(4062490)
78
1119
0.70
2.66
1.2
1.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
14
323
0.43
2.66
21.2
31.6
ug/l
6.0
7.0
1.82
14
287
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
80
554
1.45
2.61
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
80
554
1.45
2.61
1.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1979
21115
0.92
2.60
1.4
1.5
g/l
2.3
2.3
0.53
936
11840
(3021879) Hepatitis B virus core Ab [Presence] in Serum
695
6174
1.13
2.60
1.4
1.3
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
10
263
0.38
2.59
1.5
1.7
mg/l
7.4
9.8
—
10
211
(3000570) Elastase.pancreatic [Mass/mass] in Stool
313
3729
0.84
2.57
1.4
1.4
ug/g
278.9
277.6
0.04
187
2161
(3020874) Milk IgE Ab [Units/volume] in Serum
26
477
0.54
2.55
1.0
1.0
u/ml
0.4
1.7
—
8
146
(3007916) DNA double strand Ab [Titer] in Serum
5
166
0.30
2.52
1.0
1.3
—
195.6
—
0
11
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
16
343
0.47
2.52
1.7
1.7
ug/l
9.0
8.8
0.05
16
343
(43055514) Macroprolactin [Presence] in Serum or Plasma
24
122
1.97
2.49
1.3
1.5
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
13
300
0.43
2.49
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
13
300
0.43
2.49
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
13
300
0.43
2.49
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
13
300
0.43
2.49
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
66
445
1.49
2.48
2.1
2.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
51
325
1.57
2.47
1.2
1.7
e6/l
2806.0
16782.8
1.27
27
160
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
415
4810
0.86
2.46
1.8
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
131
1708
0.76
2.45
1.3
1.2
—
—
—
0
0
(4094501)
247
2983
0.82
2.37
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
111
1472
0.75
2.36
1.7
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
22
111
1.98
2.34
1.5
1.5
—
—
—
0
0
(3020891) Body temperature
354
4137
0.85
2.34
3.6
4.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
48
735
0.65
2.33
2.1
2.1
ug/l
3.3
4.1
0.62
43
653
(3010726) Horse dander IgE Ab [Units/volume] in Serum
81
1124
0.72
2.32
1.1
1.1
u/ml
0.9
1.5
0.55
23
234
(3021788) Differential panel - Synovial fluid
174
2174
0.80
2.32
1.4
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
135
1041
1.30
2.31
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
98
1318
0.74
2.30
1.0
1.1
u/ml
1.9
3.3
1.64
44
580
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
67
461
1.46
2.30
1.1
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
66
453
1.46
2.29
1.1
1.1
u/ml
65.6
9.9
—
5
43
(3016650) Hepatitis A virus Ab [Presence] in Serum
116
1520
0.76
2.28
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
79
562
1.41
2.27
1.1
1.1
ratio
1.0
1.1
1.01
44
200
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
102
758
1.35
2.26
1.9
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
2318
21943
1.07
2.24
2.3
2.6
e6/l
7.5
7.5
0.03
2002
19013
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
177
1419
1.25
2.23
1.1
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
55
367
1.50
2.21
1.3
1.8
e6/l
969.4
3276.5
0.86
33
234
(3025577) Chromium [Mass/volume] in Blood
47
712
0.66
2.19
2.0
2.1
ug/l
2.4
2.8
0.52
40
606
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
54
795
0.68
2.18
1.0
1.0
u/ml
0.1
0.5
1.07
14
161
(3000492) Spirometry study
862
9460
0.90
2.16
1.5
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
173
2140
0.81
2.14
1.8
2.3
ug/min
68.6
70.3
0.02
87
1155
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
160
1275
1.26
2.14
3.6
3.2
nmol/l
4.7
9.8
0.58
155
1227
(3003327) Ova and parasites identified in Stool by Light microscopy
321
3748
0.85
2.13
1.6
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
43
274
1.57
2.13
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
100
749
1.34
2.12
1.3
1.4
—
—
—
0
0
(4015189)
16
320
0.50
2.12
1.8
2.7
—
—
—
0
0
(3019977) pH of Arterial blood
73
520
1.41
2.11
2.7
2.7
ph
7.4
7.4
1.30
36
192
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
52
348
1.50
2.08
2.5
2.1
ug/l
0.6
0.7
0.16
19
142
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
150
1876
0.80
2.06
1.3
1.3
nmol/l
0.2
0.2
—
7
131
(3011335) Digoxin [Mass/volume] in Serum or Plasma
18
89
2.02
2.05
2.7
2.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
246
2061
1.20
2.05
3.3
3.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
194
2359
0.82
2.05
1.8
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
66
924
0.71
2.04
1.1
1.1
u/ml
1.9
3.6
1.15
25
331
(3000060) B lymphocytes [#/volume] in Blood
10
233
0.43
2.02
1.1
2.0
e6/l
4296.0
227.1
—
5
129
(3016750) Collection duration of Urine
34
540
0.63
2.00
1.5
2.2
min
518.7
500.9
0.42
20
405
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
306
2621
1.17
1.98
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
119
1520
0.78
1.97
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
464
5238
0.88
1.95
1.4
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
265
3115
0.85
1.94
3.0
4.1
mmol/l
3.8
3.8
0.17
246
2950
(3037692) Legionella sp identified in Specimen by Organism specific culture
53
362
1.47
1.94
1.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
107
1382
0.77
1.94
1.7
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1119
10369
1.09
1.93
2.1
2.4
u/l
42.8
39.5
0.32
956
8752
(3020356) Listeria sp identified in Specimen by Organism specific culture
10
39
2.57
1.92
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
597
6631
0.90
1.91
4.1
4.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
138
1725
0.80
1.91
1.3
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
1221
13110
0.92
1.91
1.3
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
21
113
1.86
1.91
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
100
763
1.31
1.91
1.3
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
240
0.46
1.89
1.3
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
33
519
0.63
1.88
1.5
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
47
316
1.49
1.87
1.1
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
21
114
1.84
1.86
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
21
114
1.84
1.86
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
101
1306
0.77
1.86
5.8
5.0
umol/l
378.3
373.9
0.11
85
1130
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
126
995
1.27
1.86
1.1
1.1
%
96.4
94.5
0.32
119
929
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
117
1485
0.79
1.86
1.1
1.1
u/ml
1.3
1.0
0.16
47
522
(3002621) Streptococcal DNAse B [Units/volume] in Serum
15
72
2.08
1.86
1.1
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
148
1828
0.81
1.85
1.5
1.5
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
16
79
2.03
1.85
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
44
293
1.50
1.83
1.3
1.8
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
10
40
2.50
1.83
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
131
1635
0.80
1.81
1.3
1.3
nmol/l
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
35
222
1.58
1.81
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
43
286
1.51
1.81
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
56
393
1.43
1.80
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
62
856
0.72
1.80
1.2
1.3
u/ml
5.5
1.0
0.46
18
416
(3014133) Dog dander IgE Ab [Units/volume] in Serum
73
981
0.74
1.79
1.0
1.0
u/ml
2.9
3.6
0.26
30
338
(3024471) HLA-A [Type]
12
247
0.49
1.77
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
27
161
1.68
1.77
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
120
1508
0.79
1.77
1.6
1.6
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
19
337
0.56
1.76
1.5
1.3
—
2002060.1
—
0
13
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
215
2545
0.84
1.75
1.6
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
106
828
1.28
1.73
1.4
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
120
1503
0.80
1.73
1.6
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
144
1167
1.24
1.72
1.2
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
35
225
1.56
1.72
1.1
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
45
648
0.69
1.69
2.0
2.3
e6/l
456.7
544.4
0.42
38
545
(4268621)
122
973
1.26
1.69
2.3
2.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
205
1726
1.19
1.68
2.1
2.6
umol/l
37.7
33.0
1.38
160
1467
(3020630) Protein [Mass/volume] in Serum or Plasma
981
9107
1.08
1.65
2.6
2.7
g/l
66.3
66.3
0.01
874
8159
(21494890) Protein electrophoresis panel - 24 hour Urine
83
1080
0.77
1.64
2.1
2.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
47
667
0.70
1.64
1.7
1.5
u/l
5.9
5.6
0.10
39
552
(3033799) Differential panel - Peritoneal fluid
45
310
1.45
1.62
1.2
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
54
747
0.72
1.62
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
596
5414
1.11
1.62
1.2
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
51
712
0.72
1.62
1.5
2.3
ml
631.6
637.7
0.04
29
494
(3047007) Chlamydophila sp Ab [Presence] in Serum
118
1463
0.80
1.58
1.4
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
956
10275
0.92
1.57
2.1
2.1
nmol/l
379.0
378.9
0.01
872
9361
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1330
12517
1.07
1.56
2.5
2.5
umol/l
8.9
7.4
1.38
1145
10657
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
54
741
0.73
1.55
1.1
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
19
324
0.59
1.55
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
221
2579
0.85
1.55
1.8
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
174
1456
1.20
1.55
1.2
1.2
u/ml
2.9
4.0
0.53
52
476
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
67
889
0.75
1.55
1.2
1.2
titre
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
157
0.45
1.54
4.0
9.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
169
1413
1.20
1.52
1.2
1.2
u/ml
3.9
3.8
0.05
62
613
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
63
467
1.35
1.52
3.3
2.8
%
23.2
22.2
0.13
19
125
(3045424) Erythrocytes [Presence] in Urine
230
1976
1.17
1.51
1.4
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
142
0.42
1.51
2.5
1.9
umol/l
15.1
17.6
—
6
142
(40768797) Stomach Pathology biopsy report
1607
16938
0.94
1.51
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
122
1497
0.81
1.50
1.6
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
16
86
1.86
1.50
1.1
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
125
0.40
1.49
1.0
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
7704
75846
1.04
1.48
4.5
4.9
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
20
331
0.60
1.47
1.2
1.1
umol/24h
0.5
0.7
—
9
153
(3044927) Protein electrophoresis panel - Urine
91
1149
0.79
1.45
1.2
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
61
810
0.75
1.44
1.0
1.0
ng/l
38.7
47.1
0.96
48
557
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
48
344
1.40
1.43
1.2
1.2
g/l
0.3
0.3
1.08
41
281
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
115
932
1.24
1.43
2.3
2.8
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
22
133
1.66
1.42
1.4
1.3
mmol/l
3.3
1.6
0.26
14
85
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
61
807
0.75
1.41
1.0
1.0
ng/l
730.4
724.7
0.03
47
539
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
222
2565
0.86
1.40
1.2
1.3
mg/l
567.5
550.0
0.10
211
2435
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
26
399
0.65
1.40
1.1
1.1
—
—
—
0
0
(4027681)
37
528
0.70
1.38
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
233
2672
0.87
1.34
3.2
3.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
61
800
0.76
1.34
1.0
1.0
ng/l
333.2
388.0
0.46
48
558
(40768446) Kidney Pathology biopsy report
18
297
0.61
1.33
1.3
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
814
7577
1.08
1.33
3.3
2.9
e9/l
3.8
3.9
0.68
641
5579
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
105
1.72
1.32
1.1
1.1
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
41
0.00
1.31
0.0
1.0
—
1.1
—
0
22
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
0
41
0.00
1.31
0.0
1.0
—
0.0
—
0
36
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
638
5885
1.09
1.31
2.6
3.5
kpa
5.2
5.2
0.13
577
5412
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
37
521
0.71
1.29
1.1
1.1
u/l
1.0
1.1
1.16
20
252
(3023419) Bacteria identified in Sputum by Culture
109
1328
0.82
1.29
2.5
2.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
270
3055
0.88
1.28
1.1
1.2
titre
615.0
984.5
0.85
12
130
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
81
1018
0.79
1.28
1.2
1.2
u/ml
22.6
44.2
—
5
99
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
739
7948
0.93
1.28
1.2
1.2
iu/ml
166.3
146.6
0.61
283
3037
(3028433) Virus identified in Specimen by Culture
49
361
1.36
1.27
1.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
12
62
1.94
1.27
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
12
62
1.94
1.27
1.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
12
62
1.94
1.27
1.1
1.1
s
35.4
35.9
0.13
12
52
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
423
4661
0.90
1.26
1.8
2.0
u/l
42.0
40.1
1.12
374
4082
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
81
1016
0.80
1.26
1.2
1.2
u/ml
94.3
74.4
—
6
61
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
27
401
0.67
1.26
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
166
1418
1.17
1.23
2.2
2.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
129
1078
1.20
1.23
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
96
1177
0.81
1.22
1.6
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
108
1.67
1.22
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
129
1081
1.20
1.20
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
54
707
0.76
1.20
1.2
1.2
mg/l
48.9
41.6
0.19
45
597
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
204
2338
0.87
1.19
1.3
1.3
miu/ml
278.9
210.7
1.77
97
1095
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
52
683
0.76
1.18
1.2
1.1
mg/l
334.2
261.4
0.44
47
603
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
9
168
0.54
1.18
1.6
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
115
1377
0.83
1.17
1.2
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
58
446
1.30
1.16
1.1
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
22
333
0.66
1.15
1.5
1.5
%
47.1
52.0
0.20
15
284
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
35
0.00
1.15
0.0
16.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
143
1676
0.85
1.14
1.6
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
49
643
0.76
1.12
2.0
2.5
e6/l
486.9
865.0
1.50
23
289
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
198
2260
0.87
1.11
1.2
1.3
mmol/l
3.6
3.7
1.11
185
2131
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
40
539
0.74
1.10
1.1
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
33
457
0.72
1.09
1.4
1.2
nmol/l
126.7
133.2
0.49
33
457
(3022621) pH of Urine by Test strip
731
7805
0.93
1.08
3.5
3.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
21
136
1.55
1.08
1.3
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1132
11918
0.94
1.07
1.7
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1434
13706
1.05
1.06
22.3
23.1
inr
1.3
1.3
0.03
223
1912
(3025130) Human papilloma virus identified in Specimen
201
1766
1.14
1.06
1.4
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
876
9288
0.94
1.05
2.4
2.8
ng/l
168.8
174.7
0.21
795
8514
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1453
13897
1.05
1.05
2.1
2.5
%
21.3
21.3
0.02
1261
11705
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
22
145
1.52
1.05
1.0
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
752
8011
0.93
1.05
4.9
6.4
mmol/l
8.7
9.3
1.72
723
7604
(3024263) Appearance of Synovial fluid
42
556
0.75
1.04
1.4
1.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
107
1272
0.84
1.03
1.1
1.1
iu/ml
54.7
9296.8
0.55
34
257
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
27
383
0.70
1.03
1.1
1.1
miu/ml
917.4
1564.5
4.72
27
383
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
16
98
1.63
1.03
1.0
1.2
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
7
34
2.06
1.02
1.0
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
43
324
1.33
1.01
1.1
1.2
%
109.8
114.9
0.58
37
285
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
521
4830
1.08
1.01
1.1
1.1
u/ml
1.1
1.6
—
6
78
(3035320) C reactive protein [Mass/volume] in Body fluid
102
854
1.20
1.00
2.4
2.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
723
7696
0.94
1.00
2.2
2.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
290
3206
0.90
0.99
1.7
1.7
—
—
—
0
0
(4146454)
106
1254
0.84
0.98
2.7
2.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
35
257
1.36
0.98
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
44
335
1.31
0.98
1.8
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
199
0.60
0.96
1.3
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
12
69
1.74
0.96
1.1
1.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
12
69
1.74
0.96
1.1
1.1
mg/l
10.6
10.3
0.02
12
63
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
51
648
0.79
0.95
1.1
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
57
452
1.26
0.94
2.0
2.5
mmol/l
9.6
9.0
0.77
49
332
(3007566) Smooth muscle Ab [Titer] in Serum
274
3029
0.90
0.94
1.1
1.2
titre
117.7
160.0
0.31
22
255
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
117
0.51
0.93
12.5
11.0
mmol/l
5.0
4.7
—
6
117
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
6
118
0.51
0.93
1.2
1.7
—
181.3
—
0
5
(44813793)
68
834
0.81
0.93
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
32
234
1.37
0.93
1.3
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
621
5819
1.07
0.92
2.6
3.5
ph
7.4
7.4
1.41
105
791
(3017704) Immunofixation for Urine
46
589
0.78
0.92
1.7
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
59
733
0.80
0.92
1.8
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
147
1281
1.15
0.91
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
271
2454
1.11
0.90
1.4
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
59
473
1.25
0.90
1.2
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
59
473
1.25
0.90
1.2
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
268
2956
0.90
0.90
2.0
2.1
mg/l
10.3
11.3
1.54
244
2713
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
101
0.49
0.89
1.8
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
27
371
0.73
0.89
1.4
1.3
g/l
38.6
39.0
0.05
13
184
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
9
155
0.58
0.88
1.2
1.1
umol/24h
1.7
1.6
—
9
155
(3002331) Protein [Mass/volume] in Peritoneal fluid
29
211
1.38
0.88
1.1
1.4
g/l
31.0
29.2
0.27
23
171
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
403
4355
0.92
0.87
2.2
2.3
g/l
7.8
7.6
1.38
308
3211
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
30
220
1.36
0.87
1.1
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
257
2834
0.90
0.86
5.6
4.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
597
5603
1.07
0.86
2.6
3.4
mmol/l
2.1
2.1
0.03
469
4352
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
352
3238
1.09
0.86
1.2
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
98
833
1.18
0.85
5.8
6.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
93
1095
0.85
0.85
1.4
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
403
4347
0.92
0.84
2.2
2.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
32
239
1.34
0.83
1.6
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
36
468
0.77
0.83
2.5
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
137
0.58
0.83
1.3
1.5
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
24
171
1.40
0.82
1.4
1.2
mmol/l
2.3
1.9
0.91
18
95
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
403
4342
0.93
0.82
2.2
2.3
g/l
3.8
3.7
0.66
288
3059
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
251
2761
0.91
0.82
1.1
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
17
249
0.68
0.81
1.1
1.0
u/ml
0.6
0.9
—
8
127
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
72
862
0.83
0.81
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
88
1035
0.85
0.81
2.5
2.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
397
3683
1.08
0.80
2.6
3.7
mmol/l
25.2
25.2
0.13
355
3370
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
20
283
0.71
0.80
1.3
1.4
ng/l
69.0
91.9
1.89
20
283
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
378
4077
0.92
0.80
2.0
2.3
g/l
9.7
10.0
0.66
305
3346
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
316
3433
0.92
0.79
2.9
3.4
ratio
4.2
4.2
0.00
15
266
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
6
33
1.82
0.79
2.7
2.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
46
575
0.80
0.79
1.2
1.5
%
2.3
3.3
0.54
11
105
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
9
147
0.61
0.78
3.0
3.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
181
2019
0.89
0.78
1.3
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
13
199
0.65
0.78
1.1
1.2
—
1123.6
—
0
11
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
53
651
0.81
0.78
1.1
1.1
nmol/l
1.6
6.6
—
8
130
(3040151) Glucose [Moles/volume] in Capillary blood
125
1093
1.15
0.78
3.3
6.5
mmol/l
7.0
7.5
0.87
103
897
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
66
792
0.83
0.77
1.5
1.3
nmol/l
1.5
1.5
0.02
61
711
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
138
1216
1.14
0.77
4.8
6.5
mg/l
12.7
12.3
0.38
125
1108
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
437
4679
0.93
0.77
2.4
2.7
%
1.1
1.2
2.06
437
4653
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
173
1547
1.12
0.76
2.1
2.0
mg/l
25.8
25.2
0.04
48
413
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
186
0.64
0.76
1.6
1.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
18
256
0.70
0.75
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
17
244
0.70
0.75
1.1
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
474
4444
1.07
0.74
2.6
3.8
mmol/l
24.6
24.5
0.29
417
3977
(3006184) Hemoglobin [Mass/volume] in Capillary blood
258
2361
1.09
0.74
2.1
2.2
g/l
125.4
126.6
0.36
176
1653
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
17
243
0.70
0.73
1.1
1.2
mg/l
0.8
20.0
—
8
182
(3008295) Osmolality of Serum or Plasma
102
1174
0.87
0.73
1.2
1.4
mosm/kgh2o
274.1
274.4
0.04
76
889
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
63
754
0.83
0.72
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3041
31076
0.97
0.72
1.6
1.7
mmol/l
1.4
1.3
0.95
2482
25796
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
93
1076
0.86
0.72
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
171
0.64
0.71
2.8
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
4048
41197
0.97
0.71
3.3
3.6
ng/l
29.4
59.7
1.53
2928
27839
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
29
378
0.77
0.71
1.8
2.3
umol/l
40.9
57.8
2.19
18
284
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
29
378
0.77
0.71
13.7
14.5
nmol/l
1375.3
1505.8
0.39
23
361
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
27
355
0.76
0.70
10.4
10.1
nmol/l
707.6
842.3
0.98
27
341
(3002619) Bacteria identified in Specimen by Culture
16
229
0.70
0.70
1.2
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
42
336
1.25
0.70
1.1
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
22
160
1.38
0.70
1.4
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
39
488
0.80
0.70
1.9
2.9
%
42.5
41.4
0.08
11
169
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
85
987
0.86
0.69
1.1
1.1
—
89.5
—
0
15
(4198724)
14
205
0.68
0.69
1.0
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
329
3542
0.93
0.69
3.0
3.5
mg/l
49.0
75.0
0.52
261
2879
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1541
14923
1.04
0.69
2.0
2.4
g/l
2.4
2.4
1.49
1409
13661
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1087
11297
0.96
0.68
1.6
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
443
4160
1.07
0.68
2.6
3.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
451
4797
0.94
0.68
2.8
3.1
mmol/l
25.7
25.5
0.61
445
4674
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
87
1006
0.86
0.68
1.1
1.1
—
7.6
—
0
9
(3010838) Calcium [Moles/time] in 24 hour Urine
86
741
1.16
0.68
1.5
1.7
mmol/24h
5.4
5.5
—
10
47
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
30
231
1.30
0.67
1.2
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
41
329
1.25
0.67
1.0
1.1
—
—
—
0
0
(44806420)
24
318
0.75
0.67
2.1
2.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
215
1963
1.10
0.67
2.5
2.8
kpa
8.3
8.1
0.77
198
1815
(3003181) Sodium [Moles/volume] in Urine
210
2299
0.91
0.66
1.4
1.4
mmol/l
57.7
61.4
0.80
161
1822
(44816559) Phosphatidylethanol [Mass/volume] in Blood
124
1396
0.89
0.66
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
67
567
1.18
0.66
2.6
3.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
13
86
1.51
0.66
1.2
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
144
1606
0.90
0.65
1.4
1.4
mu/l
54.1
50.4
0.06
129
1413
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1179
11375
1.04
0.65
3.4
4.2
u/l
258.7
248.2
1.22
1112
10669
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
432
4592
0.94
0.65
2.3
2.7
%
0.7
0.7
0.13
415
4399
(3048929) Epstein Barr virus Ab [Presence] in Serum
201
2201
0.91
0.64
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
185
1682
1.10
0.64
2.6
2.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
318
2961
1.08
0.63
2.5
2.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
129
0.62
0.63
14.8
10.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
214
2334
0.92
0.63
3.7
3.7
mg/l
23.6
23.8
0.03
114
1438
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3466
35285
0.98
0.62
2.3
2.5
u/l
57.9
58.1
0.07
3180
32080
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
31
243
1.28
0.62
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
101
0.59
0.62
3.3
4.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
17
234
0.73
0.62
1.3
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
88
1007
0.87
0.61
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
142
1577
0.90
0.61
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
30
235
1.28
0.61
1.4
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
66
771
0.86
0.61
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1690
16439
1.03
0.60
1.4
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
24
312
0.77
0.60
1.1
1.2
pmol/l
238.6
346.3
1.60
18
219
(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
24.3
—
0
6
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
320
3423
0.93
0.59
1.2
1.2
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
3.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
40
326
1.23
0.59
1.2
1.1
%
94.0
95.1
0.07
24
139
(3051101) Glucose [Moles/volume] in Cord blood
13
186
0.70
0.59
4.4
6.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
90
1024
0.88
0.59
1.1
1.1
—
33.7
—
0
12
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
14
97
1.44
0.58
1.1
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
599
6283
0.95
0.58
5.4
6.7
mmol/l
25.3
24.9
1.96
560
5833
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
56
473
1.18
0.58
1.5
1.5
pmol/l
14.9
15.6
0.72
41
398
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
10
64
1.56
0.58
1.1
1.0
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
0.1
—
0
12
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
132
1466
0.90
0.58
1.1
1.2
u/ml
271.1
296.0
0.38
80
892
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
7
112
0.62
0.58
1.4
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
331
3531
0.94
0.58
2.9
3.5
mg/l
36.6
39.9
0.15
261
2867
(3036071) Salmonella sp Ab [Titer] in Serum
21
276
0.76
0.57
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
115
0.61
0.57
4.0
7.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
91
801
1.14
0.57
1.5
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
69
797
0.86
0.56
1.1
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
89
0.56
0.55
2.0
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
48
402
1.19
0.55
1.9
2.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
6
37
1.62
0.55
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
524
5502
0.95
0.55
1.9
2.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
808
8398
0.96
0.54
2.2
2.5
e9/l
71.6
71.1
0.13
594
6312
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
123
0.65
0.54
1.1
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
142
1288
1.10
0.54
1.1
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
124
0.64
0.54
1.1
1.4
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
17
228
0.75
0.54
1.9
2.3
ug/l
5.2
3.7
—
9
93
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
700
6716
1.04
0.53
1.3
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
23
178
1.29
0.52
2.7
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
900
8685
1.04
0.52
4.6
6.1
mmol/l
1.3
1.3
0.07
870
8424
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
31
382
0.81
0.52
2.8
2.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
33
268
1.23
0.52
1.3
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
98
0.61
0.52
1.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
414
0.82
0.52
1.5
1.9
umol/l
273.3
114.2
0.61
18
231
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
81
917
0.88
0.51
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
81
917
0.88
0.51
1.1
1.2
—
—
—
0
0
(4211845)
73
639
1.14
0.51
4.6
3.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
24
303
0.79
0.50
2.7
2.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
81
915
0.88
0.50
1.1
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
41
488
0.84
0.50
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
364
3443
1.06
0.50
1.7
1.7
mg/l
2.7
3.2
0.69
301
2463
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
151
1382
1.09
0.50
1.3
1.3
—
34.7
—
0
10
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
33
270
1.22
0.49
1.1
1.1
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
22
171
1.29
0.49
3.9
6.5
%
67.9
68.9
0.05
17
133
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
27
216
1.25
0.49
1.2
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
19
145
1.31
0.48
1.1
1.2
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
7
108
0.65
0.48
1.0
1.0
—
5.9
—
0
13
(3045683) HLA typing for celiac disease panel - Blood or Tissue
52
604
0.86
0.48
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
32
262
1.22
0.48
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
327
3460
0.94
0.47
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
572
5964
0.96
0.47
2.7
3.1
g/l
123.8
126.4
2.32
554
5835
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
276
2934
0.94
0.47
1.4
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
33
272
1.21
0.47
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
79
888
0.89
0.46
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
327
3456
0.94
0.46
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
82
919
0.89
0.46
1.1
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1372
13375
1.03
0.46
3.5
4.8
mmol/l
1.0
1.0
0.14
1256
12276
(3044290) Cell count panel - Cerebral spinal fluid
196
2106
0.93
0.46
1.2
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
82
918
0.89
0.45
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
82
918
0.89
0.45
1.1
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
33
396
0.83
0.45
1.2
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
85
760
1.12
0.45
1.2
1.4
mmol/l
2.2
2.2
0.16
80
703
(3041096) Erythrocytes [Presence] in Urine by Automated
2740
27853
0.98
0.45
3.8
3.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
89
798
1.12
0.45
1.7
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1593
15570
1.03
0.44
1.9
2.0
s
29.1
29.4
1.39
1546
15088
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
153
1658
0.92
0.44
1.2
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
43
503
0.85
0.44
1.9
1.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
439
4191
1.05
0.44
4.4
4.7
%
1.5
1.6
5.04
421
3929
(3008536) Aspergillus sp Ab [Presence] in Serum
24
192
1.25
0.44
2.0
1.8
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
10
69
1.45
0.44
1.2
1.1
u/l
8.2
11.8
—
10
69
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
219
2049
1.07
0.44
1.5
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
144
1563
0.92
0.44
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
46
534
0.86
0.43
1.3
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
9
127
0.71
0.43
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
64
564
1.14
0.43
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
121
1322
0.91
0.43
1.1
1.1
g/l
1.5
1.5
0.66
110
1173
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
174
0.75
0.43
4.4
9.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
37
312
1.19
0.43
1.2
1.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
5
31
1.61
0.43
1.2
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
351
3691
0.95
0.43
2.7
3.0
g/l
0.2
0.3
4.13
120
1231
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
63
555
1.14
0.43
1.4
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
254
2392
1.06
0.42
3.1
3.3
nmol/l
0.8
0.8
0.78
196
1900
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
324
3414
0.95
0.42
1.9
2.2
ug/l
333.2
504.3
0.94
292
3185
(3027945) Reticulocytes/100 erythrocytes in Blood
1083
11128
0.97
0.42
2.0
2.5
%
2.0
1.8
1.94
952
9781
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
16
122
1.31
0.42
1.1
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
84
933
0.90
0.42
2.0
2.3
e9/l
1.3
1.1
0.75
55
564
(3000285) Sodium [Moles/volume] in Blood
20
158
1.27
0.41
1.3
1.2
—
—
—
0
0
(3009883) Potato IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.2
—
0
10
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.3
—
0
6
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
86
776
1.11
0.40
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
143
1545
0.92
0.40
1.5
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
246
2320
1.06
0.40
2.5
2.9
mmol/l
25.9
25.3
1.08
210
2036
(3020491) Glucose [Moles/volume] in Blood
82
738
1.11
0.40
1.7
1.9
mmol/l
6.7
7.0
0.58
66
510
(3028679) Herpes simplex virus Ab [Presence] in Serum
51
445
1.15
0.40
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
121
1111
1.09
0.40
1.3
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
124
1140
1.09
0.40
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
392
4101
0.95
0.40
2.1
2.3
g/l
3.2
3.1
1.19
297
3122
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
0.2
—
0
7
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
357
3404
1.05
0.40
2.1
2.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
48
550
0.87
0.39
1.2
1.4
promille
1.3
1.1
0.36
38
398
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33
278
1.19
0.39
1.1
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
7
101
0.69
0.39
1.1
1.3
pmol/l
8.3
16.6
—
7
89
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
39
334
1.17
0.39
1.1
1.1
%
93.3
91.7
0.13
23
139
(3007930) Methemoglobin/Hemoglobin.total in Blood
431
4131
1.04
0.39
4.4
4.8
%
0.9
0.9
0.49
412
3873
(3047352) Trisomy 18 risk [Likelihood] in Fetus
86
778
1.11
0.39
1.4
1.4
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
63
560
1.13
0.38
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
78
864
0.90
0.38
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
66
589
1.12
0.38
4.8
3.4
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
26
215
1.21
0.38
1.5
1.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
10
136
0.74
0.37
2.0
5.8
ug/min
34.8
40.6
—
10
104
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
246
2329
1.06
0.37
2.4
2.9
mg/l
1.4
1.6
1.90
220
2116
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
115
0.70
0.37
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
3339
33794
0.98
0.36
2.8
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1310
12823
1.02
0.35
1.3
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
62
555
1.12
0.35
1.4
1.7
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
9
125
0.72
0.35
1.0
1.1
—
5.4
—
0
22
(21494815) CD4 cells/100 lymphocytes in Specimen
67
743
0.90
0.34
2.0
2.0
%
40.2
40.8
—
9
92
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
73
1.37
0.34
1.1
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
18
222
0.81
0.34
1.0
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
139
1490
0.93
0.34
1.3
1.2
pmol/l
361.7
301.0
0.28
111
1177
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
6
44
1.36
0.34
1.0
1.1
u/l
463.7
609.8
—
6
34
(3027923) C peptide [Moles/volume] in Serum or Plasma
46
521
0.88
0.34
1.4
1.4
nmol/l
1.6
1.2
1.37
34
409
(3027801) Oxygen [Partial pressure] in Arterial blood
1122
11474
0.98
0.34
5.3
6.4
kpa
13.1
12.6
1.59
1070
10948
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
18
221
0.81
0.33
2.0
2.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
6
46
1.30
0.33
1.3
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1123
11479
0.98
0.33
5.3
6.4
kpa
5.2
5.1
0.95
1070
10960
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
65
719
0.90
0.33
1.7
2.0
%
12.0
14.8
1.16
16
298
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
47
416
1.13
0.32
2.3
2.6
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
24
285
0.84
0.32
1.2
1.4
%
46.8
38.7
0.46
18
185
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
37
322
1.15
0.32
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
325
3390
0.96
0.32
1.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
23
274
0.84
0.32
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
28
327
0.86
0.31
1.9
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
140
1311
1.07
0.31
2.0
2.1
u/ml
8.5
1149.1
0.92
140
1282
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
123
1317
0.93
0.31
1.0
1.1
u/ml
1.8
3.6
1.75
48
515
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
19
156
1.22
0.31
1.2
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
212
2227
0.95
0.29
6.1
6.4
mmol/l
105.3
104.8
0.74
194
2001
(3000012) Reticulocyte production index
64
582
1.10
0.29
1.5
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
26
303
0.86
0.29
1.4
1.8
—
—
—
0
0
(3039000) Anion gap in Blood
212
2226
0.95
0.29
6.1
6.4
mmol/l
10.6
11.0
1.13
194
2000
(3021960) Folate [Moles/volume] in Serum or Plasma
2634
26656
0.98
0.29
1.5
1.5
nmol/l
21.5
21.9
0.64
2155
22226
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
74
806
0.92
0.29
2.4
2.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
68
621
1.10
0.29
1.9
2.0
u/field
2.3
2.3
0.01
45
420
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
356
3693
0.96
0.28
2.2
2.5
g/l
0.5
0.9
2.00
296
3112
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
111
0.72
0.28
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
50
450
1.11
0.28
2.3
2.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
119
0.76
0.27
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
311
3230
0.96
0.27
1.7
1.8
iu/l
31.7
14.1
0.28
119
1135
(3029396) Erythrocyte agglutination [Presence] in Blood
14
113
1.24
0.26
2.8
2.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
25
289
0.86
0.26
2.0
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
69
749
0.92
0.26
1.1
1.0
mg/l
304.3
299.5
0.27
59
653
(3033705) Calcium.ionized [Moles/volume] in Venous blood
133
1255
1.06
0.26
2.5
2.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
17
141
1.21
0.26
1.2
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
19
160
1.19
0.25
1.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
87
810
1.07
0.25
1.1
1.3
titre
1024.0
464.0
—
5
57
(3000093) Morphology [Interpretation] in Blood Narrative
87
933
0.93
0.25
1.1
1.1
—
—
—
0
0
(4133840)
17
202
0.84
0.24
1.2
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
11
87
1.26
0.24
1.2
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
27
236
1.14
0.24
1.3
1.3
nmol/l
89.6
123.1
1.37
21
153
(3000991) Gas panel - Venous blood
832
8155
1.02
0.24
5.3
7.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
40
360
1.11
0.23
1.1
3.6
mg/l
4464.3
677.3
0.40
33
238
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
32
284
1.13
0.23
2.2
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
32
284
1.13
0.23
2.2
2.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
134
1271
1.05
0.23
2.5
2.3
mmol/l
4.0
4.0
0.01
134
1262
(3035285) Chloride [Moles/volume] in Venous blood
134
1271
1.05
0.23
2.5
2.3
mmol/l
105.2
105.6
0.46
134
1262
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
17
143
1.19
0.23
1.1
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3262
32344
1.01
0.22
2.6
2.8
ng/l
1041.6
1164.5
0.99
2783
27585
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
708
6933
1.02
0.22
1.8
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
939
9223
1.02
0.22
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
123
1165
1.06
0.22
4.8
4.6
u/ml
44.4
129.7
3.01
35
312
(3006922) Hepatitis E virus Ab [Presence] in Serum
62
670
0.92
0.22
1.1
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
7
95
0.74
0.22
1.6
1.9
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
46
503
0.91
0.21
7.7
10.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
26
229
1.14
0.21
1.9
2.3
mmol/l
6.2
7.0
1.36
15
143
(3006576) Bicarbonate [Moles/volume] in Blood
28
248
1.13
0.21
3.9
6.1
mmol/l
24.8
25.5
0.65
21
231
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
125.3
—
0
11
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
285
2944
0.97
0.21
2.1
2.4
g/l
0.0
0.0
0.00
254
2691
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
21.1
—
0
13
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
11
89
1.24
0.20
1.4
1.2
ug/l
92.0
125.6
—
6
55
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
289
2983
0.97
0.20
2.1
2.4
g/l
0.0
0.0
0.23
254
2701
(3014576) Chloride [Moles/volume] in Serum or Plasma
1275
12574
1.02
0.20
5.0
6.3
mmol/l
104.2
104.1
0.32
1246
12317
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
45
412
1.09
0.20
1.2
1.4
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
87
819
1.06
0.20
1.1
1.2
mmol/l
32.1
32.9
0.13
78
680
(3003396) Base excess in Arterial blood by calculation
1129
11456
0.98
0.20
5.2
6.4
mmol/l
1.3
1.3
0.01
927
9218
(3016502) Oxygen saturation in Arterial blood
990
10055
0.98
0.19
5.4
6.8
%
95.8
95.9
0.08
952
9678
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
30
269
1.12
0.19
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1644
16255
1.01
0.19
2.1
2.4
umol/l
12.7
12.5
0.54
1524
14880
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
61
569
1.07
0.18
1.1
1.3
mmol/l
5.9
5.9
0.08
56
530
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
804
8174
0.98
0.18
3.1
3.2
pmol/l
4.5
4.4
1.94
716
7148
(3036603) Volume of Urine
81
764
1.06
0.18
1.3
1.5
ml
2264.2
1883.5
1.22
19
184
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
141
1471
0.96
0.18
1.2
1.3
u/ml
111.0
121.5
1.00
32
346
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
84
794
1.06
0.18
1.1
1.3
titre
29.1
60.5
2.49
11
62
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
60
1.17
0.17
1.7
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
95
1000
0.95
0.17
3.6
3.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
38
414
0.92
0.17
1.1
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
7
61
1.15
0.17
1.6
5.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
16
138
1.16
0.17
1.1
1.2
ng/l
163.9
69.5
0.73
11
91
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
512
5224
0.98
0.17
7.1
8.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
927
9405
0.98
0.17
5.7
7.1
g/l
118.2
118.3
0.03
891
9062
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
62
1.13
0.17
1.1
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
59
552
1.07
0.17
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
67
0.75
0.17
1.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
67
0.75
0.17
1.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
69
732
0.94
0.17
1.3
2.0
%
10.0
10.7
0.85
69
732
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
177
1709
1.04
0.16
1.2
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
12
101
1.19
0.16
1.9
2.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
23
256
0.90
0.16
1.1
1.2
mu/l
25.4
71.4
2.72
18
180
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1493
14781
1.01
0.15
4.4
4.8
%
33.0
33.6
1.36
950
9587
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
446
4548
0.98
0.15
1.5
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
312
3195
0.98
0.15
2.2
2.3
g/l
0.0
0.0
1.11
276
2902
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
9
79
1.14
0.15
1.0
1.1
mmol/l
8.8
8.4
—
9
79
(3006270) Folate [Moles/volume] in Blood
90
943
0.95
0.15
1.1
1.2
nmol/l
343.1
359.1
0.35
78
794
(3026692) Albumin [Mass/volume] in Peritoneal fluid
26
236
1.10
0.14
1.1
1.3
g/l
16.0
14.0
0.49
21
187
(3027035) Albumin [Mass/time] in 24 hour Urine
7
87
0.80
0.14
1.1
1.3
—
83.9
—
0
12
(4024509)
147
1420
1.04
0.14
1.7
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
11
93
1.18
0.14
1.1
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
90
0.78
0.14
2.4
2.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
751
7410
1.01
0.14
2.5
2.9
kpa
4.4
4.5
0.70
722
7204
(3021447) Carbon dioxide [Partial pressure] in Venous blood
905
8942
1.01
0.13
2.7
3.5
kpa
5.8
5.8
0.83
878
8709
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
8
98
0.82
0.13
2.5
2.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
8
100
0.80
0.13
8.4
6.5
—
—
—
0
0
(4212803)
8
100
0.80
0.13
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
460
4679
0.98
0.13
1.7
1.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
46
432
1.07
0.13
1.3
2.7
u/l
204.0
210.7
0.38
46
426
(3029075) Extractable nuclear Ab panel - Serum
35
325
1.08
0.13
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
237
2427
0.98
0.12
1.4
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
903
8931
1.01
0.12
2.7
3.5
mmol/l
2.2
2.2
0.05
749
7439
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
65
682
0.95
0.12
1.6
2.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
50
527
0.95
0.11
1.3
1.8
%
107.6
100.6
0.66
45
479
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
122
1257
0.97
0.10
1.3
1.3
mmol/l
7.5
7.5
0.05
98
913
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
44
1.14
0.10
9.0
8.2
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
5
45
1.11
0.09
1.0
1.0
u/ml
0.0
0.3
—
5
39
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
53
507
1.05
0.09
1.4
1.6
nmol/l
1.7
3.8
2.32
47
410
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
60
576
1.04
0.09
1.2
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
308
3128
0.98
0.09
5.2
5.6
mmol/l
1.3
1.3
0.07
275
2760
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
14
126
1.11
0.09
1.1
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
100
1029
0.97
0.08
1.5
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
12
107
1.12
0.08
1.9
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
98
1008
0.97
0.08
1.3
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
472
4667
1.01
0.08
1.6
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
963
9558
1.01
0.08
1.5
1.5
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
5
62
0.81
0.08
1.2
1.1
—
42.4
—
0
15
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
97
943
1.03
0.08
2.1
2.2
u/field
3.5
2.7
0.49
42
373
(40757373) Influenza virus identified in Isolate
20
185
1.08
0.08
1.2
1.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
47
450
1.04
0.08
2.0
2.1
ug/min
19.1
70.1
—
9
73
(44806071)
11
123
0.89
0.08
1.0
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
43
449
0.96
0.07
1.4
1.6
ug/l
0.5
0.4
1.03
29
293
(3009015) Lactate [Moles/volume] in Synovial fluid
15
137
1.10
0.07
1.1
1.3
mmol/l
7.4
6.1
—
6
63
(3022475) Manganese [Moles/volume] in Blood
8
77
1.04
0.07
1.6
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
20
186
1.08
0.07
1.1
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
85
827
1.03
0.07
1.7
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
84
0.83
0.07
1.0
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
495
4904
1.01
0.07
2.4
2.5
e6/l
0.3
0.3
0.38
479
4724
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2108
21158
1.00
0.06
3.3
3.7
ng/l
97.9
267.9
9.19
1644
16268
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
9
102
0.88
0.06
1.2
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
9
102
0.88
0.06
1.8
1.6
umol/l
38.9
48.6
—
9
102
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
439
4431
0.99
0.06
1.5
1.7
g/l
1.7
1.6
0.79
360
3782
(3005011) Chlamydia sp Ab [Titer] in Serum
16
148
1.08
0.06
1.7
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
29
276
1.05
0.06
1.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
67
652
1.03
0.05
1.4
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
509
5129
0.99
0.05
6.4
8.1
mmol/l
24.6
24.6
0.12
474
4786
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
15
161
0.93
0.05
2.4
2.7
u/field
0.4
0.8
1.49
15
161
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
32
307
1.04
0.05
1.7
1.4
mmol/l
8.3
8.2
0.05
18
183
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
30
288
1.04
0.04
1.3
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
52
534
0.97
0.04
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
52
533
0.98
0.04
1.2
1.3
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
13
121
1.07
0.03
1.2
1.1
u/ml
2.1
0.4
—
8
74
(3024928) Oxygen saturation in Venous blood
199
1971
1.01
0.03
2.1
3.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
614
6167
1.00
0.03
1.3
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
159
1605
0.99
0.03
2.1
2.9
%
57.5
63.4
3.02
159
1598
(3035933) Granulocytes/100 leukocytes in Blood
23
221
1.04
0.03
3.6
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
184
1855
0.99
0.02
2.5
4.9
iu/ml
1199.7
736.0
0.19
11
285
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
27
261
1.03
0.02
1.2
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
92
932
0.99
0.02
1.2
1.6
u/ml
35.1
22.1
—
9
190
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
45
460
0.98
0.02
3.6
4.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
29
299
0.97
0.02
1.3
2.0
ug/l
1.8
2.4
0.60
14
184
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
117
0.94
0.01
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
17
163
1.04
0.01
1.9
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1111
11126
1.00
0.01
1.6
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
23
237
0.97
0.01
1.2
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
75
758
0.99
0.01
1.2
1.3
mmol/l
10.7
11.7
0.46
21
183
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
73
737
0.99
0.01
1.1
1.1
iu/ml
9.0
10.0
0.13
19
153
(40760892) CBC W Ordered Manual Differential panel - Blood
2272
22709
1.00
0.00
3.7
4.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
60
606
0.99
0.00
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
13
127
1.02
0.00
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
25
253
0.99
0.00
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
10
96
1.04
0.00
1.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
45
454
0.99
0.00
1.1
1.1
iu/ml
—
3.8
—
0
20
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
20
205
0.98
0.00
3.7
5.3
u/l
41.9
44.4
—
8
87
(3022689) Creatine [Moles/volume] in Urine
32
315
1.02
0.00
1.4
1.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
43
435
0.99
0.00
1.1
1.1
ng/l
568.3
801.8
0.20
14
101
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5951
59512
1.00
0.00
2.5
2.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
57
572
1.00
0.00
1.4
1.6
ug/l
7.6
8.8
0.33
51
518
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
60
602
1.00
0.00
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
27
269
1.00
0.00
1.1
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
99
991
1.00
0.00
2.7
2.9
mg/l
79.9
24.0
0.58
68
653
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
119
1.01
0.00
1.1
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
23
229
1.00
0.00
1.5
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
18
179
1.01
0.00
1.2
1.1
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
16.7
—
0
8
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
8
82
0.98
0.00
1.4
1.2
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
341
3410
1.00
0.00
2.0
2.2
g/l
38.2
37.6
1.02
273
2869
(3007147) Virus identified in Stool by Electron microscopy
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
94
0.96
0.00
1.3
1.6
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
8
83
0.96
0.00
1.1
1.3
mmol/l
141.6
157.5
—
8
71
(3002853) Influenza virus B Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
6
0.00
0.00
0.0
6.2
—
5.0
—
0
6
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
9
0.00
0.00
0.0
4.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
27
270
1.00
0.00
1.8
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
87
0.92
0.00
1.1
2.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
9
92
0.98
0.00
1.1
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
71
710
1.00
0.00
1.6
1.8
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
5
58
0.86
0.00
1.0
1.0
u/ml
0.0
0.3
—
5
43
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
9
90
1.00
0.00
1.1
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
61
0.98
0.00
1.2
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L02BG – L02BG Aromatase inhibitors
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).